Further Assessment of PPCPs in Feed Grade Chicken Feather Meal Including Potential Sources by Chen, Zhixin
Clemson University
TigerPrints
All Theses Theses
5-2015
Further Assessment of PPCPs in Feed Grade
Chicken Feather Meal Including Potential Sources
Zhixin Chen
Clemson University
Follow this and additional works at: https://tigerprints.clemson.edu/all_theses
This Thesis is brought to you for free and open access by the Theses at TigerPrints. It has been accepted for inclusion in All Theses by an authorized
administrator of TigerPrints. For more information, please contact kokeefe@clemson.edu.
Recommended Citation
Chen, Zhixin, "Further Assessment of PPCPs in Feed Grade Chicken Feather Meal Including Potential Sources" (2015). All Theses.
2082.
https://tigerprints.clemson.edu/all_theses/2082
FURTHER ASSESSMENT OF PPCPs IN FEED GRADE CHICKEN FEATHER MEAL 
INCLUDING POTENTIAL SOURCES 
A Thesis 
Presented to 
the Graduate School of 
Clemson University 
In Partial Fulfillment 
of the Requirements for the Degree 
Master of Science 
Chemistry  
by 
Zhixin Chen 
May 2015 
Accepted by: 
Joseph S. Thrasher, Committee Chair 
Stephen E. Creager 
George Chumanov 
 ii
ABSTRACT 
 
 The poultry and rendering industries have played important roles in both the diets 
of humans as well as environmentally sustainable development. However, a recent article 
published by Dr. D. C. Love and co-workers at Johns Hopkins Center for a Livable 
Future revealed concerns that pharmaceutical and personal care products (PPCPs) might 
be able to re-enter the human food supply by being present in feed grade chicken feather 
meal, i.e., be consumed by and accumulate in the tissue of chickens or other animals. 
Their study showed twenty-four PPCPs that were detected above the reporting limits in a 
total of twelve feather meal samples (five feed grade and seven fertilizer grade) bought in 
the United States and China.[1]  
 Since this publication may have flaws in terms of the specific origin of the 
samples of chicken feather meal, and insufficient evidence existed to support the source 
of the contamination found in the feather meal samples, it was thought that addition 
studies were warranted. Samples of raw chicken feathers and fresh chicken feather meal 
were either collected or received from three (3) rendering plants from different 
geographical regions of the country. To analyze the samples, EPA method 1694 was 
followed, and the conditions of an HPLC-MS/MS (high-performance liquid 
chromatography tandem mass spectrometer) were adjusted to test the performance of 
low-concentration (ppb level) drug detection of sixteen analytes: acetaminophen, 
erythromycin, norgestimate, sulfachloropyridazine, sulfadimethoxine, sulfamerazine, 
sulfamethazine, sulfamethizole, sulfamethoxazole, thiabendazole, enrofloxacin, 
norfloxacin, 1,7-dimethylxanthine, caffeine, ofloxacin, and diphenhydramine. The results 
 iii
indicated that the mass spectrometer used, which contains a quadrupole ion-trap analyzer, 
has a lower sensitivity and thus a higher detection limit for the aforementioned sixteen 
analytes than a triple quadrupole analyzer, which is the standard instrument 
recommended by the EPA method and AXYS Analytical Services Ltd. In order to 
continue the project, the samples were then sent to AXYS Analytical Services Ltd., the 
same firm that carried out the analyses for the Johns Hopkins study. The results showed 
that these samples of chicken feather meal were not nearly as contaminated as those 
studied in the aforementioned publication, and that the contaminants may come in part 
from the raw chicken feathers and accumulates in the dissolved air filtration (DAF) 
system. The poultry industry should take care of the source of diphenhydramine, 
anhydrochlortetracycline (ATCT), and sulfadimethoxine, which were in high 
concentrations in our samples.  
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 CHAPTER ONE 
 
INTRODUCTION 
I. The Poultry and Rendering Industries 
The United States poultry industry is the world’s largest producer.[2] In 2013, the 
U.S. manufactured 8.52 billion broilers and sold 185 million chickens.[3] Meanwhile, the 
poultry industry produces an estimate of 11 billion pounds of waste every year.[4] In this 
case, the rendering industry has over 100 years of history in making continuous efforts in 
converting the secondary animal by-products into beneficial commodities,[5] and to help 
avoid the serious potential hazards brought by unprocessed animal by-products to animal 
health, human health, and the environment.[6] Annually, the rendering industry recycles 
around 59 billion pounds of perishable materials from poultry and livestock, meat and 
food processing. The supermarket and restaurant industry contribute the majority of its 
by-products to the feed industry as high-energy fats and high-quality protein ingredients 
for diet supplement and other efficient productions.[7] Among these, about 2 billion 
kilograms (5 billion pounds) of feathers, one of the poultry industry's by-products, is 
produced annually. Feather meal is the most common final product produced from the 
feathers.[8] Through hydrolyzing under great pressure and heat, grinding and drying, 
feathers are converted to feather meal and are used to formulate animal feed and organic 
fertilizer.[9] 
In the poultry industry, companies provide the chicken feed and FDA (food & 
drug administration) approved pharmaceutical compounds and vaccines to maintain flock 
health.[10] A total of forty-four feed additives are currently allowed in the market 
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according to the Feed Additive Compendium in 2015.[11] For example, the additives that 
are allowed for chicken nutritional needs (egg production/feed efficiency/growth 
promotion) and medicinal uses (air saculitis/chronic respiratory disease 
(CRD)/blackhead/histomaniasis/bluecomb/mud fever/non-specific enteritis etc.) are listed 
in Table 1.1.   
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Table 1.1. Use level of nutritional addivtives and medines from the Feed Additive Compendium 
2015 by chicken species in 2015.11 (The use levels may vary in terms of the level needed to 
prevent/cure different diseases). 
Feed Additives Nutritional Uses level (g/ton) 
Medicinal Uses level 
(g/ton) 
Amprolium   ~113.5-227 
Bacitracin Methylene 
Disalicylate ~4-50 ~100-200 
Bacitracin Zinc ~4-50 ~100-200 
Bambermycins 1-2   
Chlortetracycline 10-50 ~100-500 
Clopidol   113.5 
Cyromazine   5.0 (ppm) 
Decoquinate   27.2 
Diclazuril   0.91 
Hygromycin B   8-12 
Lasalocid   68-113 
Lincomycin ~2-4 2 
Monensin   90-110 
Narasin   ~54-90 
Narasin/Nicarbazin   54-90 
Neomycin/Oxytetracycline 10-50 ~100-500 
Nicarbazin   ~90.8-181.6 
Nitarsone   170.1 
Oxytetracycline 10-50 ~100-500 
Penicillin ~2.4-50   
Robenidine Hydrochloride   30 
Salinomycin   40-60 
Semduramicin   22.7 
Sulfadimethoxine and 
Ormetoprim 5:3   113.5 and 68.1 
Tylosin ~4-50 800-1000 
Virginiamycin ~5-15 20 
Zoalene   ~36.3-113.5  
 
In the rendering industry, raw materials are handled and treated by heat to remove 
the moisture content and micro-organisms. Through draining and pressing, melted oil is 
separated from the solids, and rest of the solids fraction is then grounded into a 
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powder.[12] Four rendering process methods exist: sterilization of animal by-products, 
which kills all forms of microbials; hydrolyzing of feather by-products, which add water 
to feather by-products by chemical process to cause the feathers fall apart; coagulating of 
blood by-products and drying of animal by-products.[13] 
II. Project Objectives 
Dr. D. C. Love and his co-workers at the Johns Hopkins Center for a Livable 
Future were concerned that the pharmaceuticals induced by feed additive or other sources 
of antimicrobials in the poultry industry might stay in secondary production, even after 
the rendering process, and re-enter the human food supply through chicken feather 
meal.[1] In this case, these pharmaceuticals become pollutants or PPCPs (Pharmaceuticals 
and Personal Care Products), defined by the EPA (Environmental Protection Agency) as 
“any product used by individuals for personal health or cosmetic reasons or used by 
agribusiness to enhance growth or health of livestock.”[14] In Dr. D. C. Love’s paper, 
published in 2012 in Environmental Science & Technology, he consigned AXYS 
Analytical Services Ltd. to test a total of twelve feather meal samples from the U.S. and 
China and stated that 19 out of the 59 tested antimicrobials were detected in the samples, 
including six drug classes: sulfonamides, macrolides, fluoroquinolones, tetracyclines, 
folic acid antagonists, and streptogramins. He alerted that the antimicrobials detected are 
approved for use in industrial poultry production,[1] suggesting these PPCPs were 
introduced by the poultry industry.  
However, as pointed out by C. L. Hofacre of the University of Georgia’s College 
of Veterinary Medicine, this study seems to be flawed as both insufficient information 
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about the source, age, etc. of the chicken feather meal samples was given and no attempt 
was made to eliminate possible sources of contamination.[15] Mark Bland, a member of 
the American Association of Avian Pathologist, also mentioned that seven out of twelve 
samples studied in the paper were described as “fertilizers”, which should not be 
considered as “reentry route,” and the analytes were found near the detection limit.[16] 
Besides, Barry Kelly suggested the sampling technique is questionable due to the fact that 
samples from China could not be considered as a representative of the sample conditions 
for U.S.[17] In addition, no information was given in the original publication suggesting 
how much the measured levels of PPCPs lie above either background levels or minimum 
detection limits. Furthermore, Dr. Love and his coworkers later published two corrections 
to their article in which the sample that they originally claimed to have been from North 
Carolina, was actually from Pennsylvania, and the number of turkeys raised in the U.S. 
should be 247 million instead of 80 million per year.[18] 
The primary objective of this project was to either refute or substantiate the 
conclusions in this publication that raised concerns about pharmaceuticals and personal 
care products (PPCPs) reentering the human food supply from chicken feather meal. 
Chicken feather meal samples (feed grade) of defined origin, as well as the corresponding 
samples of water (both plant and recycled flush), municipal water, and chicken feathers 
were collected and prepared for analysis. In the Johns Hopkins paper, the PPCPs detected 
above the reporting limits were listed and divided into the groups below: acetaminophen, 
erythromycin, norgestimate, sulfachloropyridazine, sulfadimethoxine, sulfamerazine, 
sulfamethazine, sulfamethizole, sulfamethoxazole, thiabendazole, enrofloxacin, 
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norfloxacin, 1,7-dimethylxanthine, caffeine, ofloxacin, diphenhydramine, and 
ormetoprim from the Group 1 PPCPs; and 4-epioxytetracycline (EOTC), 
isochlortetracycline (ICTC), and oxytetracycline (OTC) from the Group 2 PPCPs. PPCPs 
are partitioned into four groups based on their analysis conditions. Group 1 and Group 2 
PPCPs are analyzed under acidic extraction and positive electrospray ionization (ESI+) 
conditions, but the conditions of the LC gradient programs (flow mixture and flow rate) 
are different; Group 3 PPCPs are analyzed under acidic extraction and negative 
electrospray ionization (ESI-), while Group 4 PPCPs are analyzed under basic extraction 
and ESI+.[18] More detail information can be found in Appendix A, Table A.6-A.9. 
Depending on the results, the project aimed to provide more refutable data and/or 
determine the source or cause of contamination.  
III. LC/MS/MS in Analysis of Contaminants 
Among all the newly developed analytical tools and methods, various 
spectroscopies (atomic absorption spectroscopy, atomic emission spectroscopy, Raman 
spectroscopy, X-ray fluorescence spectroscopy, etc.), mass spectrometry, thermal 
analysis, etc., LC/MS/MS has shown the greatest success in the analysis of contaminants 
due to the limitation of gas chromatography in separations of non-volatile and thermally 
unstable chemicals and to improvement in mass spectrometry in terms of the atmospheric 
pressure ionization and electrospray techniques. [19] HPLC is a separation technique that 
is involved in the adsorption, partition, and ion exchange between the mobile and 
stationary phases, which is widely used in the separation of various pharmaceuticals, 
pesticides, biological samples, etc. [20] In chromatography, the interval between the instant 
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of injection and the detection of the component is called the retention time, which usually 
varies with the identity of each component.[21] The structural information of each 
composition is analyzed by the MS/MS. The mass of precursor ion and fragmentation ion 
generated in the collision cell are distinct and unique. Figure 1.1 shows the chemical 
structure of norgestimate and the MS/MS spectrum of precursor ion and fragmentation 
ion, which is also called parent-daughter ions. In the case of norgestimate, the precursor 
(parent) is charged by ESI and formed [C23H31NO3+H]+ ion, the mass/charge ratio (m/z) 
is 370. During the collision, norgestimate ion goes through the McLafferty rearrangement 
and lose the newly formed acetyl, the main fragmentation (daughter) ion is 
[C21H27NO+H]+ and its m/z is 310.  
 
 
Figure 1.1: The chemical structure and MS/MS spectrum of norgestimate, measured with 
electrospray ionization-quadrupole ion trap MS/MS. 
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Quadrupole time-of-flight (Q-TOF), triple quadrupole (QqQ), and quadrupole 
ion-trap (QIT) MS/MS are the three most often used analysis methods for structural 
information. The Q-TOF MS/MS can give full-scan data of the precursor ion and 
accurate mass of fragmentation ions, so it is more sensitive in scan mode compared to the 
third quadrupole of the QqQ. But the cost is high, and Q-TOF can only do quasi-selected 
reaction monitoring (quasi-SRM), which means it has less sensitivity for quantitation of 
analytes. The QqQ MS/MS consists of two single quadrupoles with a collision cell in 
between, combining the simplicity of a quadrupole MS with the high efficiency of a TOF 
MS analyzer.[20] The QqQ is sensitive for quantitation with multiple reaction monitoring 
(MRM) [sometimes called selected reaction monitoring (SRM)], and the cost is 
moderate, so it has often been used in quantitative analysis. But the QqQ is the least 
sensitive in scan mode. The QIT contains two hyperbolic electrodes and a ring electrode. 
A QIT can create stable trajectories for ions of either a certain m/z or a m/z range; the 
unwanted ions will collide with the wall or eject from the trap.[23-25] Ion selection, ion 
activation, and acquisition of fragment ion spectra happen in the same place, which 
makes it possible to do higher order MSn detection.[26,27] Also, recently developed QIT 
MS/MS can also do SRM experiments. However, a low-mass cutoff (LMCO) is the 
major disadvantage of QIT, which means it cannot simultaneously store ions over the full 
m/z range.  
Therefore, a secondary objective of this project is to investigate the possibility to 
use the least expensive cost QIT analyzer instead of the QqQ analyzer in mass 
spectrometer of HPLC-MS/MS instrument, which is suggested in EPA Method 1694 and 
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also used by the authors of Reference 1 at AXYS Analytical Services Ltd. If the HPLC-
QIT-MSn can also do a good job in the quantitative detection of PPCPs, then one could 
also extend the application of QIT-MS to the trace level of drugs in the environment. 
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CHAPTER TWO 
EXPERIMENTAL 
I. Sample Collection 
 
 Three pre-tests chicken feather meal samples in bags from Plant A, Plant B and 
Plant C were provided by Dr. Annel Greene, Director of ACREC.  
A field trip was made to Plant 1, located in the southeastern United States, to 
collect test samples for the study. A tour of the rendering plant was given to help 
understand how the samples were processed in order to better trace the possible sources 
of contaminants. Samples of both fresh chicken feather meal and chicken feathers were 
collected in wide-mouth bottles (Thermo Scientific, heavy-duty bottle, HDPE, 2-
L/Thermo Scientific amber rectangular bottle, HDPE, 2-L). Composite samples of the 
plant’s poultry feather meal product over a recent three-month period were also received. 
Later local water samples [plant water (two sources), dissolved-air filtration or DAF 
water-in, dissolved-air filtration or DAF water-out, municipal water, etc.] were collected 
in clean bottles (Thermo Scientific, heavy-duty bottle, HDPE, 4-L/Wheaton 4-L square 
bottle with vinylite–lined cap) for trace analysis. (The results for the liquid samples will 
be discussed in my co-worker Ms. Chen Liu’s Thesis as well as in any joint publications 
that will also include the results being described herein for the solid samples.) Samples 
collected from the plant were maintained in a cooler around 0 C with either blue ice or 
ice. Samples were stored in a freezer (< -10 C) in the laboratory within three (3) hours 
after the sample collection. A bag of peat moss was also purchased from the local store, 
which was treated to study the matrix effect and used for the quality control group. 
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Later permission was received from two other plants: Plant 2 and 3 in U.S. to 
obtain their raw samples. Instead of collecting the chicken feathers and chicken feather 
meal samples from a single poultry processing plant, gathering samples from a number of 
plants in different areas of the U.S. will represent a broader spectrum of product 
originating from many different poultry processing plants around the country. Necessary 
supplies were shipped to these Plants: four new bottles (Thermo Scientific amber 
rectangular bottle, HDPE, 2-L) for storing the chicken feather and chicken feather meal; 
enough large bottles (1-L) for DAF water-in, DAF water-out, plant water, and municipal 
water samples; and blue ice with other packing material in a cooler, so that the plants 
could collect and ship fresh samples at low temperature to our laboratory at the Advanced 
Materials Research Laboratory in Anderson, SC. At the same time, the chain of custody 
paper work was sent with the cooler to guarantee that personnel at the plant would record 
the required information on each sample. Sample names, collecting location, and 
collection date and time could be found on the chain of custody form, which became an 
important factor to determine the authenticity and conditions of samples when collected.  
After the bottles filled with target samples were received, information on the 
chain of custody paperwork was recorded and organized in files. For each solid samples, 
10-20 g of well mixed samples was grounded into particles smaller than 1mm, and the 
powders were then put into 50-mL new centrifuge tubes with screw caps (CORNING, 
plug seal cap, polypropylene). For each liquid samples with visible particles inside, 2-L 
of well-shaken samples were filtered through a hazardous waste filtration system 
(Millipore YT30 142HW) with microfiber filters of 47-mm circles to remove the visible 
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particles. Each clear aqueous solution was stored in 1-L heavy-duty bottles; and the 
filtered particles were collected in 50-mL centrifuge tubes and treated as solid samples 
for future tests.  Each type of sample was prepared in more than two aliquots, one aliquot 
was used for the PPCPs test, one was saved for a back-up, and the reminder of raw 
materials were stored in the original sample bottles. Then every centrifuge tubes and 
bottles was numbered such that the order would match the information offered by the 
chain of custody paperwork. Later, each sample bottle or tube was sealed in one or two 
zip-lock bags to avoid possible cross contamination. All the samples were kept in a 
freezer in the dark at < -10 C until proceeding to the sample preparation step. 
II. Sample Processing   
 
Collected samples and peat moss went through the following steps, and each 
sample batch was extracted during the same 12-hour shift. 
i. Preparation of Chemicals and Materials 
Reagents and commercial standards were obtained from commercial vendors. 
Reagents: sodium phosphate monobasic monohydrate (ACS reagent, CAS no. 10049-21-
5, Ricca), ethylenediaminetetraacetic acid tetrasodium salt dehydrate (98%-102%, CAS 
no. 10378-23-1, Sigma), methanol (ACS reagent, CAS no. 67-56-1, Fisher Scientific), 
dichloromethane (CAS no. 75-09-2, Macron), hydrochloric acid solution 6 N (certified 
5.96-6.05N, CAS no. 7732-18-5, Fisher Scientific), formic acid (LC-MS ultra, CAS no. 
64-18-6, Fluka); sixteen commercial standards: acetaminophen (≥98%, Cambridge 
Isotope Lab), sulfamethazine (≥98%, Cambridge Isotope Lab), sulfamethoxazole (≥98%, 
Cambridge Isotope Lab), diphenhydramineHCl (Cerilliant), thiabendazole (99.8%, CAS 
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no. 148-79-8, Fluka), 1,7-dimethylxanthine (CAS no. 611-59-66, Sigma), caffeine (CAS 
no. 58-08-2, Sigma), norgestimate (CAS no. 35189-28-7, Sigma), sulfachloropyridazine 
(99.4%, CAS no. 80-32-0, Fluka), sulfamerazine (99.9%, CAS no. 127-79-7, Fluka), 
norfloxacin (CAS no. 70458-96-7, Fluka), sulfadimethoxine (99.9%, CAS no. 122-11-2, 
Fluka), enrofloxacin (99.0%, CAS no. 193106-60-6, Fluka), ofloxacin (99.8%, CAS no. 
82419-36-1, Fluka) , sulfamethizole (98.9%, CAS no. 144-82-1, Fluka), erythromycin 
(≥98%, Cambridge Isotope Lab); five labeled compounds: atrazine (Ring-13C3, 99%, 
Cambridge Isotope Lab), erythromycin (N,N-dimethyl-13C2, 90%, Cambridge Isotope 
Lab), sulfamethazine (phenyl-13C6, 90%, Cambridge Isotope Lab), sulfamethoxazole 
(ring-13C6, 99%, Cambridge Isotope Lab), caffeine (trimethyl-13C3, 99%, Cambridge 
Isotope Lab). The concentrations of each solution was prepared as shown in Appendix A, 
Table A.1. In Table A.1, the original concentrations of each commercial standards and 
labeled internal standards was determined and calculated based on the target 
concentrations needed in the EPA method 1694.[19] 
Solid commercial standards were weighted by using a precision analytical balance 
of an elemental analysis instrument (PerkinElmer AD 6 autobalance controller). Liquid 
commercial standards, including five internal standards were also measured by pipette. 
After the chemicals were individually placed in micro-centrifuge tubes with screw caps 
(Neptune™ 2.0-mL pre-sterile conical-bottom), a certain amount of methanol was added 
to each tube, and the solutions were diluted to their targeted concentrations (the volumes 
of methanol added to the chemicals were calculated and are shown in Appendix A, Table 
A.1). For some solid chemicals, a secondary solvent (acetonitrile or DMSO, etc. referred 
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to in Appendix A, Table A.1 in the solvent column) was applied due the solubility 
properties of different pharmaceuticals.  
After the preparations of the sample of each PPCP with a known concentration, a 
mixture of sixteen commercial standards and 13C3-atrazine was prepared with a series of 
concentrations for producing calibration curves. The concentrations of each analyte in 
CS-1, CS-2, CS-3, CS-4 and CS-5 are listed in Appendix A, Table A.2, which strictly 
followed EPA method 1694.[19] Later the concentrations were adjusted based on the 
instrumental performance, and the new concentrations are shown in Appendix A, Table 
A.3. More information will be discussed in Chapter Three.  
The buffer solution was prepared by weighing 1.93 g NaH2PO4H2O in 99 mL of 
reagent water, and then adding 1 mL 85% H3PO4.[19] 
ii. Sample Preparation 
Based on the EPA protocol, the particle size of the samples should be smaller than 
1 mm. Since chicken feathers and some chicken feather meal particles were larger than 1 
mm, samples had to be ground, homogenized, or blended first. Hard particles were 
reduced by grinding with a mortar and pestle, and then the softer particles were reduced 
by grinding in a cryogenic mill (6870 Freezer/Mill: SPEX Sample Prep). The sample was 
frozen with liquid nitrogen to improve the grinding efficiency. Also, two peat moss 
(brand: Miracle-Gro®, Sphagnum peat moss) samples were ground and used as blank and 
ongoing precision and recovery standard (OPR) for reference matrix aliquots. Filtered 
solids from DAF water samples (only DFA water contained visible particles, other water 
samples were clear) were treated differently from the above-mentioned solid samples, 
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instead of grinding, buffer solution was added, and the solids were homogenized in 
centrifuge tubes by stirring with a glass rod. The pH of the final solution was adjusted to 
2 ± 0.5 (Fisher scientific™ accumet™ AB15 Basic pH meter). All operations were 
carried out in a fume hood in order to prevent particles from contaminating the work 
environment. 
A quantity of 0.25-0.10 g of well-mixed chicken feather and chicken feather meal 
samples were weighed (Sartorius balance) separately, and each sample was placed into a 
centrifuge tube (CORNING, plug seal cap, polypropylene). The exact weights of net 
samples were recorded. The same weighing procedure was followed for two samples of 
0.25 g each of peat moss, which were used for the method blank and the OPR sample for 
the acid fraction. After weighing, all solid samples were stored in closed container to 
prevent further drying. 
iii. Acid Fraction  
 An amount of 0.25 g of each sample or peat moss was placed in a 50-mL 
centrifuge tube, then 15-mL of pH = 2 phosphate buffer was added, followed by 5 min 
vortexing (BV 1000 vortex mixer, 115 VAC, 60 Hz, 1.5 amps). The sixteen commercial 
standards mentioned in the Preparation of Chemicals and Materials section were spiked 
only into the peat moss aliquot that served as the acid fraction OPR, the injection volume 
followed Appendix A, Table A.1. (The volumes were adjusted based on the method 
performance, since the injection volumes needed to be increased when the recovery was 
zero.) The five labeled compounds were spiked into the acid fractions of the samples and 
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QC (blank and OPR) samples. The pH of each solution was kept to 2.0 ± 0.5 by adding a 
buffer solution. After each addition, the centrifuge tube was again vortexed.  
iv. Concentration and Extraction 
After the spiking step, 20 mL of acetonitrile was added to each of the solid 
samples and the QC samples, followed by 30 minutes of sonication (AquasonicTM 
ultrasonic cleaner, model 150HT, 50/60 Hz) and 5-10 minutes of centrifugation at 3000 
rpm (VWR clinical 200 centrifuge). Extract (supernatants) of each entire sample and the 
QC samples were decanted into separate, clean 250-mL round-bottomed flasks. Then 15-
mL of phosphate buffer was added to each sample and the QC samples and the pH was 
adjusted to 2.0 ± 0.5 with HCl. A second extraction was performed by repeating the steps 
above, and the extract was added to their respective flasks. For the third extraction, only 
15 mL of acetonitrile was added to each of the tubes. The tube was sonicated and 
centrifuged, and the supernatants were decanted into their respective round-bottomed 
flasks. A filtration through a hazardous waste filtration system (Millipore YT30 142HW, 
filter paper: WhatmanTM GF/A, 47 mm circles) was carried out if particles were visible in 
any extract. In this case, squeeze bottles were used to rinse the filter three times with 
reagent water and three times with acetonitrile. 
The collected extracts from the acid fraction of the solid samples and QC samples 
were concentrated separately to a final volume of 20 - 30 mL by rotary evaporation 
(Büchi water bath B-481, Büchi rotavapor R-124, Welch DuoSeal vacuum pump) at 50 
ºC. Immediately after concentration, 200 mL of reagent water and 500 mg of 
Na4EDTA2H2O were added to the acid fraction extract. 
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v. Cleanup  
The SPE apparatus (Oasis HLB 20-cc Vac Cartridge, 1 g sorbent per cartridge, 
60-μm particle size) was assembled and the SPE HLB cartridges were attached to it. An 
SPE HLB cartridge was conditioned by eluting it first with 20 mL of methanol followed 
by 6-mL of reagent water at pH 2.0 ± 0.5. These eluents were discarded after use. After 
conditioning of the cartridges, the prepared samples were each loaded onto a separate 
cartridge at a flow rate of 5-10 mL min-1. The flow rate was controlled by a multi-
position extraction manifold (Agilent Vac Elut SPS 24 Manifold with PYREX 
borosilicate glass tube, culture, disposable rimless, 10 75 mm). Once the entire sample 
passed through the cartridge, the acid fraction cartridge was washed with 10-mL of 
reagent water to remove the EDTA. Then the cartridges were then dried under vacuum 
for approximately 5 min, followed by treatment with 12-mL of methanol, which was used 
to elute the analytes under vacuum, and later the elution was completed by gravity. Each 
eluent was collected in a respective clean centrifuge tube (Corning 15-mL centrifuge 
tube, plug seal cap, polypropylene), and concentrated to near dryness under a gentle 
stream of nitrogen in a water bath held at 50 ± 5 °C. 
At last, 3-mL of methanol was added to the concentrated acid extracts, including 
the blank and OPR samples. The final volume was adjusted to 4.0 ± 0.1 mL with 0.1% 
formic acid solution. If visible particles were presented in the extract, or if the extract was 
cloudy, the extract was filtered through a 0.2-μm filter (pressure filter). A quantify of 1-
mL of each clear extract was transferred to an HPLC/MS/MS autosampler vial for 

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analysis. The remaining 3-mL of extract was treated as backup and stored in a 
refrigerator. 
The whole process is summarized in the Figure 2.1 below, the aqueous sample 
processing steps can be found in my co-worker Ms. Chen Liu’s Thesis. 
 
 
Figure 2.1: Flow chart of determination of Group 1 pharmaceuticals and personal care products 
by LC/MS/MS. 
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III. Instrumentation 
After the samples were extracted and concentrated, they were ready for analysis 
by HPLC-MS/MS. An Agilent Technologies 1200 series HPLC tandem Bruker ESI/QIT 
MSn system (column: XTerra MS C18 125Å, particle size 3.5 μm, 1 mm  50 mm) was 
used as the HPLC/MS/MS system. The LC conditions are shown in Appendix A, Table 
A.10. The MS control software used was the Esquire 6.2.581.3 version, and the 
HPLC/MS/MS control software station was HyStar 3.2.44 SR2 version.  
First, 1 mL of a mixture of the total twenty-one analytes (sixteen native analytes 
and five labeled compounds) under CS-3 concentration was injected into the HPLC-
MS/MS to verify the instrumental performance. The parameters: parent-daughter ions 
m/z’s, amplifier (adjusted to obtain a high voltage without waveform distortion) and low 
mass cutoff values (quadrupole rejects low m/z ion)[28] were typed into the HyStar 
software control panel to identify the chemical compositions. Initial values strictly 
followed the EPA method 1694,[19] and the adjusted parent-daughter ions m/z values, 
amplifier values and cutoff values were determined by MS-MS infusion (controlled by 
Esquire software) of each pure commercial analyte. The final parameters are summarized 
in Appendix A, Table A.4.  
For example, acetaminophen, the parent-daughter ions m/z are 152.2-110.1; the 
original cutoff value was 100, and the amplifier value was 1. The above data was entered 
into the Esquire 6.2.581.3 control panel. After infusion of an aliquot of the mixture of 
standards or pure acetaminophen at CS-3 concentration, the MS spectrum of 
acetaminophen (152.2-110.1) would be shown on the screen (see Figure 1.1). The cutoff 

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values and amplifier values could be manually changed and optimized to obtain the best 
peak (highest signal-to-noise ratio, or S/N) in the spectrum in situ. These steps were 
repeated with all of the other PPCPs and labeled standards, and the spectra and settings 
were recorded for future set up in the MRM/SRM mode in HPLC-MS/MS, which, 
instead of doing one analyte at a time allows for as many as ten (10) channels to be used 
simultaneously. Thus, the structural information of ten (10) analytes can be analyzed by 
MS/MS at once. Additional information will be discussed in Chapter Three.  
After the parameters of total twenty-one target analytes were determined, HPLC-
MS/MS programs were set up for calibration curves and samples analysis. Since at most 
10 analytes channels can be monitored in the MRM mode, the total of 21 analytes had to 
be divided into three (3) subgroups, which basically means in order to collect the data on 
all 21 analytes, each sample need to be run three times. Also, in order to show 
reproducibility, two sample trails were done for each subgroup. In sum, in order to collect 
the data on all of the analytes in one sample, the sample extract had to be run a total of 
six times. More information will be discussed in Chapter Three. 
Since commercial standards are pure, while the composition of each sample 
extract was complicated, verification tests were needed to make sure that the HPLC 
column and the MS electrospray ionization components were not contaminated. Mixtures 
of commercial standards at the concentration level CS-3 were treated as verification 
group to validate the performance of the HPLC/MS/MS. If the retention time (RT) of any 
analyte fell beyond 0.4 min of the predicted RTs or the calculated concentration of any 
analytes as invalid, and the column would be replaced and/or the MS instrument would 
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be cleaned. If the former, then calibration curves would be reproduced for the new 
column. More discussion will be given in Chapter Three, Section IV. 
Since one objective of the current study is to extend the application of QIT MSn in 
PPCPs detection, it is necessary to compare the Instrumental Detection Limit (IDL, 
defines as “the lowest concentration that an analytical instrument can measure. ”[29]) of 
the ESI/QIT MSn system and QqQ MS/MS system. Since the limit of detection (LOD) is 
defined as “the lowest concentration level that can be determined to be statistically 
different from a blank”, sometimes, the IDL and LOD are operationally the same.[30] 
Thus, the IDLs of each analyte was measured and calculated in the way described below. 
The mixture of standards containing analyte X (symbol X represents analyte, e.g.: 
acetaminophen) with the concentration but near the expected limit of detection (S/N of 
the peak is within 5-10, which can be read from the window of the software) with the 
internal standard 13C3-Atrazine was prepared in triplicate. After the mixture was injected 
into the HPLC/MS/MS instrument via an auto-sampler, the standard deviation (SX) of the 
set of peak areas of this analyte can be calculated, and then it can be applied to the 
following equation to calculate the IDL:[31,32] 
IDL = tα SX 
tα: one-sided student t-distribution with n-1 degree of freedom and the level of 
significance level is α; SX: estimate of the true standard deviation of the distribution of 
sample means. 
The same protocol was applied to calculate the IDLs for all the analytes. Sample 
calculation can be found in Chapter Three. 
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CHAPTER THREE 
RESULTS AND DISCUSSION 
I. Settings for HPLC/MS/MS 
After the mixture of commercial standards was injected into the HPLC/MS/MS 
with the parameters of analytes set up in the way that was mentioned in Chapter Two, 
Section II, the data was saved as a yep file (BDal Compass Analysis file) and read by the 
Bruker Compass DataAnalysis software. A total ion current (CIT) chromatogram of a 
mixture of nine commercial standards (1,7-dimethylxanthine, caffeine, 13C3-caffeine, 
thiabendazole, 13C3-atrazine, sulfamethoxazole, diphenhydramine, 13C6-
sulfamethoxazole, 13C6-sulfamethazine) at the concentration CS-3 is shown as an 
example below in Figure 3.1. 
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Figure 3.1: Chromatogram of a mixture of commercial standards (1,7-dimethylxanthine, caffeine, 
13C3-caffeine, thiabendazole, 13C3-atrazine, sulfamethoxazole, diphenhydramine, 13C6-
sulfamethoxazole, and 13C6-sulfamethazine), the concentration of each analytes are given in 
Appendix A, Table A.3, column CS-3, respectively. 
 
In Figure 3.1, parent-daughter ions m/z are marked at the top right of each row, 
and the retention times (RTs) of each analytes can be read from the x-axis of this 
chromatogram. For example, the parent-daughter ions m/z of first analyte (the second 
row) was 181.1-124.1, plus the retention time of 6.5 minutes can be read from the 
chromatogram, matching the information of 1,7-dimethylxanthine shown in Appendix A, 
Table A.4. (or the appendix of EPA method 1694 appendix[19]). In this way, all twenty-
one analytes were determined by the m/z ratios of the parent-daughter ions and the RTs 
in order to help double-check the authenticity of each analyte, respectively. Otherwise, if 
there was no peak appeared at the m/z ratios of the target parent-daughter ions with the 
correct RTs, it means that this analyte was either nonexistent, or below the detection limit. 
II. Calibration Curves  
After the series of mixture of standards of concentrations from CS-1 to CS-5 
(Appendix A, Table A.2) were prepared individually as described in Chapter Two, 
Section III, the HPLC-MS/MS was set up for running each mixture. However, only 
diphenhydramine (0.5 ng mL-1), thiabendazole (1.25 ng mL-1) and 1,7-dimethylxanthine 
(0.125 μg mL-1) were detected in the mixture of CS-1 concentration (the lowest 
concentration in the series), and more than half of the target analytes in the mixtures 
could not be detected under the concentration of CS-2. This means that the ESI/QIT MSn 
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is not as sensitive as an QqQ MS/MS in quantitation of acetaminophen (< 0.15 μg mL-1), 
erythromycin (< 0.75 ng mL-1), norgestimate (< 7.5 ng mL-1), sulfachloropyridazine (< 
3.75 ng mL-1), sulfadimethoxine (< 0.75 ng mL-1), sulfamerazine (< 1.5 ng mL-1), 
sulfamethazine (< 1.5 ng mL-1), sulfamethizole (< 1.5 ng mL-1), sulfamethoxazole (< 1.5 
ng mL-1), enrofloxacin (< 7.5 μg mL-1), norfloxacin (< 37.5 ng mL-1), caffeine (< 37.5 ng 
mL-1) and ofloxacin (< 3.75 ng mL-1). In order to draw reliable calibration curves for the 
native analytes, each analyte from concentrations CS-1 to CS-5 must be detected by the 
HPLC-MS/MS with peaks with a S/N threshold of 5. Thus, the concentrations of sixteen 
analytes (CS-1 to CS-5) were increased to higher values, and the new concentrations used 
for the calibration curves are shown in Appendix A, Table A.3. The relationship of these 
new concentrations values are expressed by following equations (CS-n represents the 
concentration of the PPCP in the CS-n; the concentration of CS-5 were not changed): 
CS-1 = CS-5×0.075 
CS-2 = CS-5×0.1 
CS-3 = CS-5×0.25 
CS-4 = CS-5×0.4 
A series of sample calculations for producing the calibration curve of 
norgestimate is discussed below.  
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Figure 3.2: Chromatograms of norgestimate (parent-daughter ions m/z: 370.5-310.2, RT 13.7 
min) with the concentration of 0.0375 μg mL-1, 0.05 μg mL-1, 0.0125 μg mL-1, 0.2 μg mL-1, and 
0.5 μg mL-1 and internal standard 13C3-atrazine (parent-daughter ions m/z was 219.1-177.0, RT 
10.8 min, the concentration was 0.05 μg mL-1). 
 
In Figure 3.2, when the concentration of norgestimate was 0.0375 μg mL-1 (in CS-
1), the peak area of norgestimate with a RT 13.6 min could be read from the 
chromatogram as 1740332, the peak area of the internal standard 13C3-atrazine with RT 
10.8 min was 15874381, the area ratio was 
1740332
15874381
 0.1096315
. The mixture of 
commercial standards with the same concentration was run in triplicate, and the 
calculation of the peak area ratio was carried out in the same way mentioned above. Since 
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the three ratios show acceptable reproducibility, the average was calculated as the peak 
area ratio of norgestimate with a concentration of 0.0375 μg mL-1 (CS-1). Then, the peak 
area ratios of norgestimate with a concentration of 0.05 μg mL-1, 0.0125 μg mL-1, 0.2 μg 
mL-1, and 0.5 μg mL-1 were calculated in the same way, and all of the values are 
summarized in Table 3.1. Then the calibration curve of norgestimate was produced, and it 
is shown with its regression equation in Figure 3.3. 
 
Table 3.1. Data for creating the calibration curve of norgestimate with the new series of 
concentrations. 
Concentrations 
μg mL-1 
RT 
(min) 
Peak Area of 
Norgestimate 
Peak Area 
of 13C3-
Atrazine 
Ratio Ratio Average 
0.0375 
(CS-1) 
13.6 1740332 15874381 0.1096315 
0.144199 13.7 1966207 16361792 0.120171 
13.6 3305427 16299327 0.202795 
0.05 
(CS-2) 
13.6 2273561 14133545 0.160863 
0.176120 13.6 2648194 14287191 0.185354 
13.7 3466668 17315109 0.182143 
0.125 
(CS-3) 
13.7 6646075 15501192 0.428746 
0.557033 13.7 7161678 11394837 0.628502 
13.6 11655314 18987231 0.61385 
0.2 
(CS-4) 
13.7 10916585 11490142 0.950083 
0.956082 13.7 11279025 11751612 0.959785 
13.6 16047291 16744217 0.958378 
0.5 
(CS-5) 
13.7 25476431 10195048 2.498903 
2.446172 13.6 24509373 10563435 2.320209 
13.6 35344971 14029092 2.519405 
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Figure 3.3: The calibration curve of norgestimate. 
 
The calibration curves with corresponding regression equations for each of the 
other fifteen native analytes are shown in Appendix A, Figure A.1-Figure A.15. These 
data were used in the verification of the existence and the quantitation of the 
concentration of the targeted analytes.  
III. Instrumental Detection Limit 
Most of the target analytes with the original CS-1 concentration in EPA method 
1694 could not be detected with a S/N above 5. IDLs of each analytes in the ESI/QIT 
instrument should be calculated and compared with that of the QqQ instrument. The IDL 
calculation of ofloxacin is shown as an example below.  
First, the IDL of ofloxacin was estimated based on the former detection 
performance with low concentration. Solutions of ofloxacin with concentration of 1.25 ng 
mL-1 and 3.75 ng mL-1 could not be detected by the ESI/QIT MS/MS, and a signal for this 
analyte was not detected until the concentration was raised to 18.75 ng mL-1 with a S/N 
y = 5.0092x - 0.0571
R² = 0.99984
0
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1
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2
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around 10. Therefore, the estimated IDL for ofloxacin was 20 ng mL-1. Later, as 
explained in Chapter, Two Section III, a solution of 20 ng mL-1 of ofloxacin was 
prepared in triplicate and run by the HPLC-MS/MS, the results are listed below.  
 
Table 3.2: Data with which to calculate the IDL for ofloxacin. 
Trails Ratio Concentration (ng mL) 
1 0.462196 18.89 
2 0.265477 16.53 
3 0.294667 16.88 
Average -- 17.44 
Standard Deviation -- 1.27 
Detection Limit -- 8.87 
 
From above section, the calibration curve of ofloxacin is (See Appendix A. Figure 
A.15): 
Ratio = 83.32 × conc. (μg mL-1) - 1.112 
 Ratio = 0.462196 was plugged in the equation above, and the concentration was 
calculated as 18.89338 μg mL-1. Besides, t-distribution with n-1 (= 2) degree of freedom 
at 0.01 level of significance is 6.96,[33] so the IDL for ofloxacin is 6.96 × 1.27 ng mL-1 = 
8.87 ng mL-1. All the IDLs of each analytes are shown in the Appendix A, Table A.5.  
From the results, the IDLs of diphenhydramine, thiabendazole, caffeine, 
sulfadimethoxine, enrofloxacin, ofloxacin, norgestimate, sulfachloropyridazine, 
sulfamethizole, sulfamethoxazole and sulfamerazine are in ng mL-1 level or higher, which 
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explains the situation why QIT MS/MS instrument could not detect the lower 
concentrations of these analytes in the original CS-1 and CS-2 concentration levels in 
EPA method 1694.  
Symbol “NA” (in Appendix A, Table A.5) means that the IDL is not available due 
to either out of stock of the analytes or more experiments are required to calculate the 
IDLs. For example, 1,7-dimethylxanthine was prepared in 125 ng mL-1, but no signal was 
found in the mass chromatograms, which means the concentration needs to be increased 
until the S/N would be around 5-10 (i.e.: 187.5 ng mL-1 with S/N is 5.5); Meanwhile, 
norgestimate was prepared in a concentration of 37.5 ng mL-1, and the S/N was 22, which 
is larger than 10 and means that the estimated concentration should be lower. 
 In summary, since QIT-MS/MS cannot measure the concentrations as low as the 
instrument (QqQ-MS/MS) used in the EPA method for acetaminophen (0.050 μg mL-1), 
erythromycin (0.25 ng mL-1), norgestimate (2.5 ng mL-1), sulfachloropyridazine (1.25 ng 
mL-1), sulfadimethoxine (0.25 ng mL-1), sulfamerazine (0.5 ng mL-1), sulfamethazine (0.5 
ng mL-1), sulfamethizole (0.5 ng mL-1), sulfamethoxazole (0.5 ng mL-1), enrofloxacin 
(2.5 μg mL-1), norfloxacin (12.5 ng mL-1), caffeine (12.5 ng mL-1) and ofloxacin (1.25 ng 
mL-1), the IDLs of these analytes detected by QqQ-MS/MS would be smaller than that of 
QIT-MS/MS, respectively. 
IV. Analyses of Solid Samples From Rendering Plants  
i. Results from pre-test chicken feather meal samples 
Once the extract samples and QC samples were run by HPLC-MS/MS, mass 
chromatogram was analyzed in the same way as described in Sections II and III in this 
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Chapter. Each sample was run two times to show reproducibility. Figure 3.4 is the 
chromatogram from the pre-test chicken feather meal sample produced by Plant A. 
 
 
Figure 3.4: The chromatogram of the pre-test chicken feather meal sample produced by Plant A. 
 
In order to verify the existence of target analytes, both parent-daughter ions m/z 
and RT were strictly compared with Appendix A, Table A.4. For example, in Figure 3.4, 
parent-daughter ions m/z in the second row was 219.1-177.0 and the RT was 10.7 min, 
matching 13C3-atrazine; while in the last row, the parent-daughter ions m/z was 370.5-
310.2, but the RT (14.2 min and 14.7 min) does not match the RT of norgestimate (13.7 
min). To verify the performance of HPLC and MS/MS, the verification groups (mixture 
of standards with the concentrations of CS-3) were inserted into the run order of samples. 
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The parent-daughter ions m/z and the RTs of each analytes should both match the data 
shown in Appendix A, Table A.4. If the column of HPLC was contaminated, the RTs 
would change; if the parent-daughter ions m/z changes, the calibration curves would 
shift. 
The only valid signal was from enrofloxacin, of which parent-daughter ions m/z 
was 360.0-316.0 and RT was 8.4. The area ratio was 1203752
9685660
 0.124282 in the first 
trail, and 0.066408 in the second trail, so the average was 0.0953. However, enrofloxacin 
peak was also found in the total ion chromatogram of QC blank group, which means 
there might existed matrix effect or contamination induced by the background, and the 
background area ratio 0.0765 should be removed, so the final ratio was 0.0953-0.0765 = 
0.0188, then plugged in the calibration curve of enrofloxacin: Ratio = 33.604 conc. ( g 
mL-1) – 0.4784. So the concentration of enrofloxacin was 14.80 ng mL-1. Converted back 
to the original concentration, where the final extract was 4 mL, the total enrofloxacin 
collected in this extract was 14.80 ng mL-1 × 4 mL =59.20 ng from 0.2487 g of chicken 
feather meal (raw material). The concentration in ppb was 59.20 ng / 0.2487 g = 238.04 
ng g-1 = 238.04 ppb. 
All the results are shown in Appendix B, Table B.1. Only enrofloxacin (238.04 ng 
g-1) was detected in the Plant A sample; norfloxacin (2324.51 ng g-1) was detected in 
Plant B sample; while sulfamethazine (1412.33 ng g-1) and sulfadimethoxine (75.02 ng g-
1) were detected in the Plant C sample. Other analytes were not detected from these 
samples. Attention should be directed to the fact that the concentration of the found 

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analytes were very low. For example, enrofloxacin was found at 14.80 ng mL-1 in the 
extract, which was below the lowest concentration (37.5 ng mL-1) in the calibration curve 
of enrofloxacin. The error brought by the detection sensitivity might not be ignored. 
The recovery was calculated for the OPR samples, in the same way as with the 
chicken feather meal samples. The results are shown in the last column in Appendix B, 
Table B.1. However, the zero recoveries of ten analytes (sulfamethazine, 
sulfamethoxazole, 1,7-dimethylxanthine, caffeine, norgestimate, sulfachloropyridazine, 
sulfamerazine, sulfadimethoxine, sulfamethizole and erythromycin) and poor recovery of 
thiabendazole (only 2.8%) from peat moss were seen in the tests, which lead to an 
unreliability in our results of these analytes. Therefore, the original spiking volumes of 
analytes into the OPR sample were increased in order to improve the percent recovery as 
well as the method performance. 
ii. Results of PPCPs in samples from Plant 1 
The spiking volume was increased from 30 L to 90 L for diphenhydramine, 
thiabendazole, caffeine, norfloxacin, sulfadimethoxine and enrofloxacin in the OPR 
samples. Norgestimate, sulfachloropyridazine, sulfamethizole, and erythromycin were 
spiked at a four-fold volume increased when compared to the original volumes in EPA 
Method 1694, respectively. While sulfamethoxazole, 1,7-dimethylxanthine, and 
sulfamerazine were spiked at a five-fold volume (See Appendix A. Table A.5).  
The results of the quantitative detection of PPCPs in the chicken feather and 
chicken feather meal samples from Plant 1 are presented in Appendix B, Table B.2. The 
samples turned out to be very clean, that is to say, none of the analytes was detected in 
 
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the samples. The verification groups discussed in the earlier chapter were examined after 
every several runs of samples, all the results were valid due to the consistency of the RT 
and peak area ratio of each analyte. However, sulfamethazine, sulfamethoxazole, 1,7-
dimethylxanthine, norgestimate, sulfachloropyridazine, sulfamerazine, sulfamethizole 
and erythromycin still showed zero percent recovery, which brings of the uncertainty of 
the existence of the above PPCPs. Therefore, it is necessary to test the chicken feather 
and chicken feather meal samples from the Plant 1, the Plant 2 and the Plant 3, 
respectively, as well as the quality control samples of peat moss via HPLC-QqQ MS/MS, 
and meanwhile detect a broader range of PPCPs. 
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CHAPTER FOUR 
AXYS ANALYTICAL SERVICES LTD. 
Since some of the analytes have zero recoveries, which might due to the matrices 
issues or our samples of peat moss, (AXYS Analytical Services Ltd. also reported that 
troubles were met in finding a peat moss sample that give excellent recovery.) and the 
low sensitivity of the HPLC-QIT-MSn system, samples from Plant 1, Plant 2, and Plant 3 
in the U.S. were sent to AXYS Analytical Services Ltd., the same firm that the scientists 
from Johns Hopkins used. 
The earlier ground chicken feathers, chicken feather meals, and filtered DAF-in 
solid samples from Plant 1, 2 and 3, as well as the ground peat moss were prepared in 
different centrifuge tubes and sealed in double zip-lock bags. All of the samples and their 
backups were then packed in a cooler with blue ice, and the cooler was shipped to AXYS 
Analytical Services Ltd. in Canada. 
AXYS Analytical Services Ltd. tested a broader range of PPCPs: 46 Group 1 
analytes and 14 Group 2 analytes for each sample. All of the analytes and their respective 
concentrations that were found in the solid samples from the three rendering plants are 
shown in Appendix C, Tables C.1-Table C.5. The analytes for which concentrations were 
above the reporting limits (considered positive detection) are summarized in Table 4.1 
and Table 4.2. 
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Table 4.1. Summary of Group 1 PPCPs that were detected above the reporting limit in all solid 
samples. 
[Drug Class] Analytes 
Group 1 (Out of 46 Total 
Analytes) 
DAF-in 
solid 
(Plant 
1) 
Chicken 
feather 
meal 
(Plant 
1) 
Chicken 
feathers 
(Plant 1)
Chicken 
feather 
meal 
(Plant 
2) 
Chicken 
feathers 
(Plant 2)
DAF-
in solid 
(Plant 
2) 
Chicken 
feather 
meal 
(Plant 
3) 
Chicken 
feathers 
(Plant 3) 
Peat 
moss Number of 
Samples 
with This 
Analyte 
UNITS 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis)
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
Azithromycin 17 1 
Caffeine 29.4 37.7 2 
Carbamazepine 16.2 1 
Ciprofloxacin 80.4 1 
Diphenhydramine 5.11 1 
Enrofloxacin 5.11 1 
Erythromycin-H2O 5.06 5.82 2 
Lomefloxacin 7.12 1 
Ofloxacin 9.74 1 
Ormetoprim 3.02 2.37 1.36 3 
Sulfadimethoxine 0.71 3.74 2.92 2.41 13.5 0.823 6 
Number of Analytes 
Detected in Sample 
with concentration 
above the reporting 
limit 
7 1 1 2 3 3 1 1 1  
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Table 4.2. Summary of Group 2 PPCPs that were detected above the reporting limit in all solid 
samples. 
[Drug Class] Analytes 
Group 2 (Out of 14 Total 
Analytes) 
DAF-
in 
solid 
(A) 
Chicken 
feather 
meal 
(Plant 
1) 
Chicken 
feathers 
(Plant 1)
Chicken 
feather 
meal 
(Plant 2)
Chicken 
feathers 
(Plant 
2) 
DAF-in 
solid 
(Plant 
2) 
Chicken 
feather 
meal 
(Plant 
3) 
Chicken 
feathers 
(Plant 3) 
Peat 
moss Number 
of 
Samples 
with This 
Analyte 
UNITS 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
ng g-1 
(dry 
weight 
basis) 
Anhydrochlortetracycline 
[ACTC] 29 32.9 30.2  33.3 24.2  32.2  6 
Doxycycline 21.6 1 
4-Epioxytetracycline 
[EOTC] 22.8  29       2 
Isochlortetracycline 
[ICTC]       41.7   1 
Oxytetracycline [OTC] 66.5 154 2 
Number of Analytes 
Detected in Sample with 
concentration above the 
reporting limit 
3 1 3 0 1 1 1 1 1  
Total Number of 
Analytes in Samples 
(Group 1 and 2) with 
concentration above the 
reporting limit 
10 2 4 2 4 4 2 2 2  
 
A total eleven out of forty-six Group 1 analytes were detected above the reporting 
limits: they are azithromycin, caffeine, carbamazepine, ciprofloxacin, diphenhydramine, 
enrofloxacin, erythromycin-H2O, lomefloxacin, ofloxacin, ormetoprim, and 
sulfadimethoxine. A total of five out of fourteen Group 2 analytes were detected above 
the reporting limits: they are ACTC, doxycycline, EOTC, ICTC, and OTC. 
Among the aforementioned sixteen positive analytes, only four analytes out of 
sixty PPCPs, namely ormetoprim (3.02 ppb, Plant 2), sulfadimethoxine (0.71 ppb, Plant 
1; 3.74 ppb, Plant 2; 13.5 ppb, Plant 3), ACTC (32.9 ppb, Plant1), and ICTC (41.7 ppb, 
Plant 3), were detected above the reporting limits in the feed grade chicken feather meal 
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samples. The analytes acetaminophen, erythromycin, norgestimate, 
sulfachloropyridazine, enrofloxacin, norfloxacin, 1,7-dimethylxanthine, caffeine and 
ofloxacin, which were claimed to have positive detections in the samples of U.S. feed 
grade chicken feather meal in the Johns Hopkins paper, turned out to be negative 
detections (concentrations below the reporting limits). However, it should be pointed out 
that some of the concentrations of PPCPs detected in the current solid samples were 
higher than the concentrations reported in the Johns Hopkins study: ormetoprim (0.6 ppb, 
Idaho; 1.7 ppb, Tennessee), sulfadimethoxine (0.9 ppb, Idaho; 3.4 ppb, Tennessee), ICTC 
(16.6 ppb, California; 5.8 ppb, Idaho).[1] ACTC was not reported to be positive detection 
in Johns Hopkins paper, while this PPCP was detected in the feather meal sample from 
Plant 1. 
The DAF water-in solids from rendering Plant 1 contained the highest number of 
analytes: 10 positive detections for PPCPs. And the DAF water-in solid from Plant 2 
contained the second highest number of analytes: 4. A total of thirteen (13) different 
analytes were detected in the DAF water-in solids, namely azithromycin, caffeine, 
carbamazepine, ciprofloxacin, diphenhydramine, enrofloxacin, lomefloxacin, ofloxiacin, 
ormetoprim, sulfadimethoxine, OTC, EOTC and ACTC.  
In the samples of chicken feathers, seven (7) analytes, namely caffeine (37.7 ppb, 
Plant 2), erythromycin-H2O (5.06 ppb, Plant 1), ormetoprim (2.37 ppb, Plant 2), 
sulfadimethoxine (2.92 ppb, Plant 2; 0.823 ppb, Plant 3), ACTC (30.2 ppb, Plant 1; 33.3 
ppb, Plant 2; 32.2 ppb, Plant 3), EOTC (29 ppb, Plant 1), and OTC (154 ppb, Plant 1) 
were detected above the reporting limits. 
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Peat moss is the matrix used as a quality control group and to evaluate the method 
performance (blank samples and OPR samples). Even two PPCPs, erythromycin-H2O 
(5.82 ppb) and doxycycline (21.6 ppb) were found in a sample of the peat moss used in 
our laboratory.  
From the above discussion, one can see that sulfadimethoxine and ACTC were 
found in six (6) out of nine (9) solid samples; followed by ormetoprim, which was found 
in three (3) solid samples, and caffeine and oxytetracycline were found in two (2) solid 
samples.  
From Appendix C, Table C.1 to Table C.5, cloxacillin, oxacilline, penicillin G, 
and roxithromycin were either not quantifiable or the concentration were estimated. One 
can see that real samples also have matrix effects, and unknown compounds from the 
extraction of the sample may interfere with the analytical results. 
It is also possible that a correlation exists between the analytes found in the 
chicken feathers, which are the raw material for chicken feather meal, and the analytes 
found in either the chicken feather meal and/or the solid from DAF water-in samples. In 
order to check the null hypothesis of the mean concentration of each analyte in the 
chicken feather meal, chicken feathers and solid from the DAF water-in system, a 
“randomized complete block design” was created in the SAS studio academic program. 
In each statistical test, the observation is the concentration of each analytes reported by 
AXYS, the treatment is the three different sample types, and the block is the target sixty 
analytes.  
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Figure 4.1. The concentrations of 60 analytes (in ppb) in samples of DAF water-in solid, chicken 
feathers, and chicken feather meal from Plant 1. A colorful line represents a single analyte, while 
the colorful symbols dots represent the outliers. 
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Table 4.3. Plant 1: T-test (LSD) for concentration (above), this test controls the Type I error rate; 
and Tukey’s studentized range (HSD) test for concentration (below), this test controls the Type I 
experimental error rate. The level of significance is 0.05. 
Means with the same letter are not  
significantly different.
t Grouping Mean N treatment 
A 11.775 43 DAF solid 
    
B 7.518 43 Feather 
B    
B 7.370 43 Meal 
Means with the same letter are 
not  significantly different. 
Tukey Grouping Mean N treatment
A 11.775 43 DAF solid
    
B 7.518 43 Feather 
B    
B 7.370 43 Meal 
 
From Table 4.3, one can see in Plant 1 that no significant difference exists between the 
mean concentrations of analytes in the samples of chicken feather meal and chicken 
feathers. While, there is a significant difference between the solid from DAF water-in 
system and the other two samples.  
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Figure 4.2. The concentrations of 60 analytes (in ppb) in samples of DAF water-in solid, chicken 
feathers, and chicken feather meal from Plant 2. A colorful line represents a single analyte, while 
the colorful symbol dots represent the outliers. 
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Table 4.4. Plant 2: T-test (LSD) for concentration (above), this test controls the Type I error rate; 
and Tukey’s studentized range (HSD) test for concentration (below), this test controls the Type I 
experimental error rate. The level of significance is 0.05. 
Means with the same letter are not  
significantly different.
t Grouping Mean N treatment 
A 9.441 43 Meal 
A    
A 8.347 43 DAF solid 
A    
A 7.713 43 Feather 
Means with the same letter are 
not  significantly different.
Tukey Grouping Mean N treatment
A 9.441 43 Meal 
A    
A 8.347 43 DAF solid
A    
A 7.713 43 Feather 
 
From Table 4.4, one can see in Plant 2 that no significantly difference exists between the 
mean concentrations of each analyte in the sample of feather meal, chicken feathers and 
DAF water-in solid. 
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Figure 4.3. The concentrations of 60 analytes (in ppb) in samples of chicken feathers and chicken 
feather meal from Plant 3. A colorful line represents a single analyte, while the colorful symbols 
dots represent the outliers. 
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Table 4.5. Plant 3: T-test (LSD) for concentration (above), this test controls the Type I error rate; 
and Tukey’s studentized range (HSD) test for concentration (below), this test controls the Type I 
experimental error rate. The level of significance is 0.05. 
Means with the same letter are not  
significantly different.
t Grouping Mean N treatment 
A 9.8348 43 Meal 
A    
A 8.0907 43 Feather 
Means with the same letter are 
not  significantly different.
Tukey Grouping Mean N treatment
A 9.8348 43 Meal 
A    
A 8.0907 43 Feather 
 
From Table 4.5, one can see in Plant 3 that no significant difference exists 
between the mean concentrations of each analyte in the sample of chicken feather meal 
and chicken feathers. 
In conclusion, the statistical tests show that the concentrations of each analyte in 
the sample of chicken feather and chicken feather meal are correlated with each other. 
Since the samples of chicken feather and chicken feather meal from Plant 1 and 
the samples of peat moss were analyzed on both HPLC-ESI/QIT MSn system (see 
Appendix B, Table B.2) and an HPLC-QqQ MS/MS system [see Appendix C, Table C.1, 
Table C.4 (column: DAF-in solid from Plant 1) and Table C.5 (column: peat moss)], a 
comparison of the performances of these two instruments is possible. The same analytes 
were detected in the same samples by the QqQ analyzer MS (AYXS): erythromycin (5.06 
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ppb) in chicken feather meal; sulfadimethoxine (0.71 ppb) in chicken feather meal; and 
thiabendazole (5.11 ppb), caffeine (37.7 ppb), and ofloxacin (9.74 ppb) in DAF-out solids 
have were not detected by the ESI/QIT MS/MS due to the relatively higher IDLs. For 
example, 37.7 ppb of caffeine was detected in 0.25 g of DAF-in solids with the QqQ 
analyzer MS (AXYS). Had all of this caffeine been extracted into a final volume 4-mL 
for injection into an LC-MS system, the concentration of caffeine would have been 2.35 
ng mL-1, which is much lower than the IDL of caffeine (13.07 ng mL-1) determined on 
the HPLC-ESI/QIT MSn system. This does not even take into account that the percent 
recovery for caffeine was 46% on our instrument (see Appendix A, Table A.5), while 
AXYS had a better percent recovery (85%). 
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CHAPTER FIVE 
CONCLUSIONS AND FUTURE DIRECTION 
1. The fresh chicken feather meal (feed grade) analyzed in this study does not 
contain as many PPCPs as was found in the samples reported by Johns Hopkins Center 
for a Livable Future. But one should note that higher concentrations were found for four 
detected analytes: ormetoprim, sulfadimethoxine, ICTC and ACTC. 
2. The poultry industry should consider the use of ACTC and sulfadimethoxine 
versus the levels of these analytes found in the samples of chicken feather meal analyzed 
in this study. 
3. A QIT-MS/MS instrument is not as sensitive as a QqQ-MS/MS instrument, and 
the detection limits were found to be higher than on a QqQ-MS/MS instrument for all of 
the sixteen (16) target analytes studied: acetaminophen, erythromycin, norgestimate, 
sulfachloropyridazine, sulfadimethoxine, sulfamerazine, sulfamethazine, sulfamethizole, 
sulfamethoxazole, thiabendazole, enrofloxacin, norfloxacin, 1,7-dimethylxanthine, 
caffeine, ofloxacin and diphenhydramine. 
4. A correlation exists between the concentrations of sixty analytes in the samples of 
chicken feathers and chicken feather meal based on the large quantities of data reported 
by AXYS Analytical Services Ltd. 
5. The DAF water systems in the rendering plants appear to be a place of 
accumulation of PPCPs during the rendering process of chicken feather meal, e.g., 
especially in Plant 1. Thus consideration should be given with respect to whether an 
economical way could be found for removal of PPCPs at this point in the process so that 
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the risk of further contamination of chicken feather meal product is reduced. More study 
and discussions can be find in the Thesis of my co-worker Mrs. Chen Liu.[33] 
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DEFINITIONS 
Flag:  
         H = concentration is estimated; 
         N = authentic recovery is not within method/contract control limits; 
         NQ = data not quantifiable; 
         U = not detected at the reporting limit; 
         V = surrogate recovery is not within method/contract limits. 
         MAX = concentration is an estimate maximum value. 
 53
 
 
 
 
 
APPENDICES 
 54
Appendix A 
Parameters for Sample Preparation and Instrumentation Set-up 
Table A.1. Concentrations of each PPCPs commercial standards and spiking volumes 
(acid extraction). 
Compounds Weight (mg) 
V of 
solvent 
(ߤL) 
Original 
conc. (mg 
mL-1) 
Target 
conc. (ߤg 
mL-1) 
Solvent Inject V (ߤL) 
Acetaminophen NA NA 100 100 Acetonitrile 30 
Erythromycin NA NA 0.1 100 Acetonitrile 30 
Norgestimate 0.656 656 1 1000 Methanol 30 
Sulfachloropyridaz
ine 2.281 1000 2.281 2.5 Acetonitrile 30 
Sulfadimethoxine 1.4 1400 1 0.5 Methanol 30 
Sulfamerazine 1.257 1000 1.257 1 Methanol 30 
Sulfamethazine 1.984 992 2 1 Methanol 30 
Sulfamethizole 0.663 663 1 1 Methanol 30 
Sulfamethoxazole NA NA 0.1 1 Acetonitrile 30 
Thiabendazole 1.065 1065 1 1000 Methanol 30 
Enrofloxacin 0.968 968 1 1000 
Methanol: 
Acetonitrile 
=1:1 
30 
Norfloxacin 1.226 613 2 2000 Glacial acetic acid/water 30 
Diphenhydramine NA NA 1 1 Methanol 30 
Oxytetracycline 
Dihydrate 0.674 625 1 0.5 DMSO 200 
1,7-
Dimethylxanthine 1.6 1600 1 1000   
Caffeine NA NA 1 1000 
Ofloxacin 1 1000 1 1000 
Labelled 
compound      ߤg mL-1    
13C6-
Sulfamethoxazole NA NA 100
 1 Acetonitrile 100 
13C3-Caffeine NA NA 100 3 Methanol 100 
13C2-Erythromycin NA NA 100 1 Acetonitrile 100 
13C6-
Sulfamethazine NA NA 100 1 Acetonitrile 100 
Internal standard 
13C3-Atrazine NA NA 100 2.5 Nonane 80 
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Table A.2. Concentration of calibration standards for Group 1 compounds (μg mL-1) in 
EPA method.[19] 
 
Compound CS-1 CS-2 CS-3 CS-4 CS-5 
Acetaminophen 0.050 0.15 0.75 2.5 10 
Erythromycin 0.00025 0.00075 0.00375 0.0125 0.05 
Norgestimate 0.0025 0.0075 0.0375 0.125 0.5 
Sulfachloropyridazine 0.00125 0.00375 0.01875 0.0625 0.25 
Sulfadimethoxine 0.00025 0.00075 0.00375 0.0125 0.05 
Sulfamerazine 0.0005 0.0015 0.0075 0.025 0.1 
Sulfamethazine 0.0005 0.0015 0.0075 0.025 0.1 
Sulfamethizole 0.0005 0.0015 0.0075 0.025 0.1 
Sulfamethoxazole 0.0005 0.0015 0.0075 0.025 0.1 
Thiabendazole 0.00125 0.00375 0.0187 0.0625 0.25 
Enrofloxacin 0.0025 0.0075 0.0375 0.125 0.5 
Norfloxacin 0.0125 0.0375 0.187 0.625 2.5 
Diphenhydramine 0.0005 0.0015 0.0075 0.025 0.1 
1,7-Dimethylxanthine 0.125 0.375 1.870 6.250 25 
Caffeine 0.0125 0.0375 0.187 0.625 2.5 
Ofloxacin 0.00125 0.00375 0.01875 0.0625 0.25 
      
Internal standard      
13C3-Atrazine 0.05 0.05 0.05 0.05 0.05 
13C3-Caffeine 0.075 0.075 0.075 0.075 0.075 
13C6-Sulfamethoxazole 0.025 0.025 0.025 0.025 0.025 
13C2-Erythromycin 0.025 0.025 0.025 0.025 0.025 
13C6-Sulfamethazine 0.025 0.025 0.025 0.025 0.025 
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Table A.3. New concentration of calibration standards for Group 1 compounds (μg mL-1). 
Compound CS-1 CS-2 CS-3 CS-4 CS-5 
Acetaminophen 0.75 1 2.5 4 10 
Erythromycin 0.00375 0.005 0.0125 0.02 0.05 
Norgestimate 0.0375 0.05 0.125 0.2 0.5 
Sulfachloropyridazine 0.01875 0.025 0.0625 0.1 0.25 
Sulfadimethoxine 0.00375 0.005 0.0125 0.02 0.05 
Sulfamerazine 0.0075 0.01 0.025 0.04 0.1 
Sulfamethazine 0.0075 0.01 0.025 0.04 0.1 
Sulfamethizole 0.0075 0.01 0.025 0.04 0.1 
Sulfamethoxazole 0.0075 0.01 0.025 0.04 0.1 
Thiabendazole 0.01875 0.025 0.0625 0.1 0.25 
Enrofloxacin 0.0375 0.05 0.125 0.2 0.5 
Norfloxacin 0.1875 0.25 0.625 1 2.5 
Diphenhydramine 0.0075 0.01 0.025 0.04 0.1 
1,7-Dimethylxanthine 1.875 2.5 6.25 10 25 
Caffeine 0.1875 0.25 0.65 1 2.5 
Ofloxacin 0.01875 0.025 0.0625 0.1 0.25 
      
Internal standard      
13C3-Atrazine 0.05 0.05 0.05 0.05 0.05 
13C3-Caffeine 0.075 0.075 0.075 0.075 0.075 
13C6-
Sulfamethoxazole 0.025 0.025 0.025 0.025 0.025 
13C2-Erythromycin 0.025 0.025 0.025 0.025 0.025 
13C6-Sulfamethazine 0.025 0.025 0.025 0.025 0.025 
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Calibration Curve for Different Analytes 
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Figure A.1: The calibration curve of sulfachloropyridazine.  
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Figure A.2: The calibration curve of acetaminophen. 
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Figure A.3: The calibration curve of norfloxacin. 
Figure A.4: The calibration curve of norfloxacin. 
 59
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = 51.486x + 0.2585
R² = 0.99999
0
0.5
1
1.5
2
2.5
3
3.5
0 0.02 0.04 0.06
Ra
ti
o
conc.	μg	mL‐1
Erythromycin
y	=	1.0739x	‐ 0.0009
R²	=	0.99761
0
0.02
0.04
0.06
0.08
0.1
0.12
0 0.05 0.1 0.15
Ra
ti
o
conc.	μg	mL‐1
Sulfamethizole
Figure A.5: The calibration curve of sulfamethizole. 
Figure A.6: The calibration curve of erythromycin. 
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Figure A.7: The calibration curve of 1,7-dimethylxanthine. 
Figure A.8: The calibration curve of sulfamerazine. 
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Figure A.9: The calibration curve of sulfamethazine. 
Figure A.10: The calibration curve of enrofloxacin. 
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Figure A.11: The calibration curve of sulfamethoxazole. 
Figure A.12: The calibration curve of diphenhydramine. 
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Figure A.13: The calibration curve of caffeine. 
Figure A.14: The calibration curve of thiabendazole. 
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Figure A.15: The calibration curve of ofloxacin. 
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Table A.4. Parent-daughter ions settings in HPLC/MS/MS program. 
Analytes Parent-daughter ions Cutoff Amplify Retention time 
Acetaminophen 152.2-110.0 100 1 5.2 
Sulfamethazine 279.0-196.0 90 0.7 7.8 
Sulfamethizole 271.0-187.0 100 1 8 
Sulfamethoxazole 254.0-156.0 85 0.5 8.8 
Diphenhydramine 256.1-167.1 80 0.9 10 
Thiabendazole 202.1-175.1 100 0.8 7.6 
1,7-Dimethylxanthine 181.2-124.0 80 1 6.5 
Caffeine 195.0-138.0 90 0.9 7.3 
Norgestimate 370.5-310.2 100 0.5 13.7 
Sulfachloropyridazine 285.0-156.0 77 1 8.5 
Sulfamerazine 265.0-156.0 72 0.5 7.1 
Norfloxacin 320.0-276.0 85 0.6 8.1 
Sulfadimethoxine 311.0-156.0 90 0.65 9.6 
Enrofloxacin 360.0-316.0 97 0.7 8.3 
Ofloxacin 362.2-318.0 98 0.5 8.3 
Erythromycin 734.4-576.4 198 0.7 10 
13C3-Caffeine 198.0-140.0 90 0.7 7.3 
13C6-Sulfamethazine 285.1-204.0 100 1.2 7.8 
13C6-Sulfamethoxazole 260.0-162.0 85 0.7 8.7 
13C2-Erythromycin 736.4-578.4 260 0.5 10.1 
13C3-Atrazine 219.1-177.0 80 0.75 10.9 
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Table A.5. Percent recoveries from peat moss and IDLs for pure commercial standards. 
[Drug Class] Analytes Group 1 Spiking volume (ߤL) Recovery (%) IDL (ng mL-1) 
Diphenhydramine 90 55.6 1.04 
Thiabendazole 90 239.3 4.87 
Caffeine 90 46 13.07 
Norfloxacin 90 70 305.10 
Sulfadimethoxine 90 128.7 9.24 
Enrofloxacin 90 67.1 20.87 
Ofloxacin 90 62 8.87 
Norgestimate 120 18.5 NA 
Sulfachloropyridazine 120 0 45.16 
Sulfamethizole 120 0 26.94 
Erythromycin 120 0 NA 
Sulfamethoxazole 150 8.31 3.10 
1,7-Dimethylxanthine 150 106.16 NA 
Sulfamerazine 150 0 13.07 
 
 67
Table A.6. Group 1 – Acidic extraction, ESI (+) instrument conditions in EPA method 
1694.[19] 
 
LC Gradient Program LC Flow Rate 
(mL/min) 
 
Gradient 
 
General LC Conditions 
Time 
(min) Flow Mixture
1 Column Temp 40 °C 
0.0 95% Solvent A 5% Solvent B 0.15 1 Flow Rate 0.15-0.30 mL/min 
4.0 95% Solvent A 5% Solvent B 0.25 6 Max Pressure 345 bar 
22.5 12% Solvent A 88% Solvent B 0.30 6 
Autosampler tray 
temperature 4 °C 
23.0 100% Solvent B 0.30 6 MS Conditions 
26.0 100% Solvent B 0.30 6 Source Temp 140 °C 
26.5 95% Solvent A 5% Solvent B 0.15 6 
Desolvation Temp 350°C 
33 95% Solvent A 5% Solvent B 0.15 6 
Cone / Desolvation 
Gas Rate 80 L/hr / 400 L/hr 
 
1. Solvent A = 0.3% Formic Acid and 0.1% Ammonium Formate in HPLC water  
Solvent B = 1:1 Acetonitrile:Methanol 
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Table A.7. Group 2 – Acidic extraction, ESI (+) instrument conditions in EPA method 
1694.[19] 
LC Gradient Program LC Flow Rate 
(mL/min) 
 
Gradient 
 
General LC Conditions 
Time 
(min) Flow Mixture
1 Column Temp 40 °C 
0.0 10% Solvent A 90% Solvent B 0.20 1 Flow Rate 0.20-0.23 mL/min 
1.0 10% Solvent A 90% Solvent B 0.20 6 Max Pressure 345 bar 
18.0 40% Solvent A 60% Solvent B 0.23 6 
Autosampler tray 
temperature 4 °C 
20.0 90% Solvent A 10% Solvent B 0.23 6 MS Conditions 
24.0 90% Solvent A 10% Solvent B 0.23 6 Source Temp 120 °C 
24.3 10% Solvent A 90% Solvent B 0.20 6 
Desolvation Temp 400°C 
28 10% Solvent A 90% Solvent B 0.20 6 
Cone / Desolvation 
Gas Rate 70 L/hr / 450 L/hr 
 
1. Solvent A = 1:1 acetonitrile:methanol, with 5 mM Oxalic Acid  
Solvent B = HPLC H2O, with 5 mM Oxalic Acid 
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Table A.8. Group 3 – Acidic extraction, ESI (-) instrument conditions in EPA method 
1694.[19] 
LC Gradient Program LC Flow Rate 
(mL/min) 
 
Gradient 
 
General LC Conditions 
Time 
(min) Flow Mixture
1 Column Temp 40 °C 
0.0 60% Solvent A 40% Solvent B 0.2 1 Flow Rate 0.200 mL/min 
0.5 60% Solvent A 40% Solvent B 0.2 6 Max Pressure 345 bar 
7.0 100% Solvent B 0.2 6 Autosampler tray temperature 4 °C 
12.5 100% Solvent B 0.2 6 MS Conditions 
12.7 60% Solvent A 40% Solvent B 0.2 6 Source Temp. 100 °C 
16 60% Solvent A 40% Solvent B 0.2 1 
Desolvation Temp. 350°C 
    
Cone / Desolvation 
Gas Rate 50 L/hr / 300 L/hr 
 
2. Solvent A = 0.1% Ammonium Acetate and 0.1% Acetic Acid in HPLC water  
Solvent B = 1:1 Methanol:Acetonitrile 
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Table A.9. Group 4 – Basic extraction, ESI (+) instrument conditions in EPA method 
1694.[19] 
LC Gradient Program LC Flow Rate 
(mL/min) 
 
Gradient 
 
General LC Conditions 
Time 
(min) Flow Mixture
1 Column Temp 40 °C 
0.0 2% Solvent A 98% Solvent B 0.25 1 Flow Rate 0.25 mL/min 
5.0 30% Solvent A 70% Solvent B 0.25 6 Max Pressure 345 bar 
12.0 30% Solvent A 70% Solvent B 0.25 6 
Autosampler tray 
temperature 4 °C 
12.5 2% Solvent A 98% Solvent B 0.25 6 MS Conditions 
16.0 2% Solvent A 98% Solvent B 0.25 6 Source Temp 120 °C 
    Desolvation Temp 350°C 
    
Cone / Desolvation 
Gas Rate 70 L/hr / 400 L/hr 
1. Solvent A = 0.1% Acetic Acid/Ammonium Acetate Buffer 
 Solvent B = Acetonitrile 
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Table A.10. Group 1 – Acidic extraction, ESI (+) instrument conditions in HPLC-MS/MS 
at the University of Alabama. 
LC Gradient Program LC Flow Rate 
(mL/min) 
 
Gradient 
 
General LC Conditions 
Time 
(min) Flow Mixture
1 Column Temp 40 °C 
0.0 95% Solvent A 5% Solvent B 0.15 1 Flow Rate 0.15-0.30 mL/min 
2.0 95% Solvent A 5% Solvent B 0.25 6 Max Pressure 345 bar 
10.5 12% Solvent A 88% Solvent B 0.30 6 
Autosampler tray 
temperature 4 °C 
11.5 100% Solvent B 0.30 6 MS Conditions 
13.0 100% Solvent B 0.30 6 Source Temp 140 °C 
13.5 95% Solvent A 5% Solvent B 0.15 6 
Desolvation Temp 350°C 
16.5 95% Solvent A 5% Solvent B 0.15 6 
Cone / Desolvation 
Gas Rate 80 L/hr / 400 L/hr 
 
1. Solvent A = 0.3% Formic Acid and 0.1% Ammonium Formate in HPLC water  
Solvent B = 1:1 Acetonitrile:Methanol 
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Appendix B 
The Concentration of PPCPs in Solid Samples Detected at Alabama 
Table B.1. The concentration of each PPCPs in three pre-test chicken feather samples 
from Dr. Greene. 
[Drug Class] Analytes 
Plant A 
ppb   
(ng g-1) 
Plant B 
ppb    
(ng g-1) 
Plant C 
ppb   
(ng g-1) 
Recovery 
from peat 
moss (%) 
Sulfamethazine U U 1412.33 0 
Sulfamethoxazole U U U 0 
Diphenhydramine U U U 67.0 
Thiabendazole U U U 2.8 
1,7-Dimethylxanthine U U U 0 
Caffeine U U U 0 
Norgestimate U U U 0 
Sulfachloropyridazine U U U 0 
Sulfamerazine U U U 0 
Norfloxacin U 2324.51 U 84.6 
Sulfadimethoxine U U 75.02 0 
Enrofloxacin 238.04 U U 47.1 
Ofloxacin U U U 77.0 
Sulfamethizole U U U 0 
Erythromycin U U U 0 
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Table B.2. The concentration of each PPCPs in the chicken feather, chicken feather meal, 
DAF water-in and DAF water-out samples collected from Plant 1 in the U.S. 
[Drug Class] Analytes 
Chicken 
feather 
ppb 
(ng/g) 
Chicken 
feather 
meal 
DAF 
in 
solid 
DAF 
out 
solid 
Recovery 
from peat 
moss (%) 
Sulfamethazine U U U U 0 
Sulfamethoxazole U U U U 0 
Diphenhydramine U U U U 55.6 
Thiabendazole U U U U 239.3 
1,7-Dimethylxanthine U U U U 0 
Caffeine U U U U 46.0 
Norgestimate U U U U 0 
Sulfachloropyridazine U U U U 0 
Sulfamerazine U U U U 0 
Norfloxacin U U U U 70.0 
Sulfadimethoxine U U U U 128.7 
Enrofloxacin U U U U 46.1 
Ofloxacin U U U U 62.0 
Sulfamethizole U U U U 0 
Acetaminophen U U U U 133.5 
Erythromycin U U U U 0 
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Appendix C 
The Concentration of PPCPs in Solid Samples Reported by AXYS Analytical Services 
Ltd. 
Table C.1. The concentration of each PPCPs detected in the chicken feather and chicken 
feather meal samples collected from Plant 1 in the U.S. 
 Chicken feather meal from Plant 1 Chicken feather from Plant 1 
Sample Size 0.508g (dry) 0.519g (dry) 
UNITS Flag ng g
-1 (dry weight 
basis) Flag ng g
-1 (dry weight basis) 
Acetaminophen U 29.5 U 28.9 
Azithromycin U 2.95 U 2.89 
Caffeine U 29.5 U 28.9 
Carbadox U 2.95 U 2.89 
Carbamazepine U 2.95 U 2.89 
Cefotaxime U 11.8 U 11.6 
Ciprofloxacin U 11.8 U 11.6 
Clarithromycin U 2.95 U 2.89 
Clinafloxacin U 11.8 U 11.6 
Cloxacillin U H 5.91 U H 5.78 
Dehydronifedipine U 1.18 U 1.16 
Diphenhydramine U 1.18 U 1.16 
Diltiazem U 0.591 U 0.729 
Digoxin U 11.8 U 11.6 
Digoxigenin U 20.2 U 37.6 
Enrofloxacin U 5.91 U 5.78 
Erythromycin-H2O U 4.53  5.06 
Flumequine U 2.95 U 2.89 
Fluoxetine U 2.95 U 2.89 
Lincomycin U 5.91 U 5.78 
Lomefloxacin U 5.91 U 5.78 
Miconazole U 2.95 U 2.89 
Norfloxacin U 29.5 U 28.9 
Norgestimate U 11.5 U 8.66 
Ofloxacin U 2.95 U 2.89 
Ormetoprim U 1.18 U 1.16 
Oxacillin U H 5.91 U H 5.78 
Oxolinic Acid U 1.18 U 1.16 
Penicillin G U H 5.91 U H 5.78 
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Penicillin V U 5.91 U 5.78 
Roxithromycin NQ  NQ  
Sarafloxacin U 29.5 U 28.9 
Sulfachloropyridazine U 2.95 U 2.89 
Sulfadiazine U 2.95 U 2.89 
Sulfadimethoxine  0.71 U 0.578 
Sulfamerazine U 1.29 U 1.33 
Sulfamethazine U 1.18 U 2.04 
Sulfamethizole U 2.45 U 2.15 
Sulfamethoxazole U 2.42 U 1.9 
Sulfanilamide U 29.5 U 28.9 
Sulfathiazole U 2.95 U 2.89 
Thiabendazole U 2.95 U 2.89 
Trimethoprim U 2.95 U 2.89 
Tylosin U 11.8 U 11.6 
Virginiamycin M1 U 10.6 U 6.95 
1,7-Dimethylxanthine U 118 U 116 
% Moisture  4.21  62.7 
13C2-15N-
Acetaminophen (% 
Recovery) 
V 227  149 
13C3-Caffeine (% 
Recovery) V 177  113 
d10-Carbamazepine (% Recovery) 82.3  86.8 
13C3-15N-Ciprofloxacin (% 
Recovery) 150  111 
13C2-Erythromycin-H2O (% 
Recovery) 96.8  91.9 
D5-Fluoxetine (% Recovery) 62  80.7 
13C6-Sulfamethazine (% Recovery) 92  71.5 
13C6-Sulfamethoxazole (% 
Recovery) 91.4  80.4 
D6-Thiabendazole (% Recovery) 48.5  65.5 
13C3-Trimethoprim (% Recovery) 120  108 
Anhydrochlortetracycli
ne [ACTC]   32.9   30.2 
Anhydrotetracycline 
[ATC] U 29.5 U 28.9 
Chlortetracycline 
[CTC] U 11.8 U 11.6 
Demeclocycline U 29.5 U 28.9 
Doxycycline U 11.8 U 11.6 
4-
Epianhydrochlortetracy
cline [EACTC] 
U 118 U 116 
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4-
Epianhydrotetracycline 
[EATC] 
U 29.5 U 28.9 
4-Epichlortetracycline 
[ECTC] U 29.5 U 28.9 
4-Epioxytetracycline 
[EOTC] U 11.8   29 
4-Epitetracycline [ETC] U 11.8 U 11.6 
Isochlortetracycline 
[ICTC] U 11.8 U 11.6 
Minocycline U 118 U 116 
Oxytetracycline [OTC] U 11.8   154 
Tetracycline [TC] U 11.8 U 11.6 
% Moisture   4.21   62.7 
D6-Thiabendazole (% 
Recovery)   96.9   95.4 
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Table C.2. The concentration of each PPCPs detected in the chicken feather and chicken 
feather meal samples collected from Plant 2 in the U.S. 
 Chicken feather meal from Plant 2 Chicken feather from Plant 2 
Sample Size 0.498g (dry) 0.517g (dry) 
UNITS Flag ng g
-1 (dry weight 
basis) Flag ng g
-1 (dry weight basis) 
Acetaminophen U 30.1 U 29 
Azithromycin U 3.48 U 2.9 
Caffeine U 30.1  37.7 
Carbadox U 3.01 U 2.9 
Carbamazepine U 3.01 U 2.9 
Cefotaxime U 12.1 U 11.6 
Ciprofloxacin U 12.1 U 11.6 
Clarithromycin U 3.01 U 2.9 
Clinafloxacin U 23.7 U 15.1 
Cloxacillin U H 6.03 U H 5.81 
Dehydronifedipine U 1.21 U 1.16 
Diphenhydramine U 1.21 U 1.16 
Diltiazem U 0.603 U 0.581 
Digoxin U 12.1 U 11.6 
Digoxigenin U 25.5 U 35.4 
Enrofloxacin U 6.03 U 5.81 
Erythromycin-H2O U 4.62 U 4.45 
Flumequine U 3.01 U 2.9 
Fluoxetine U 3.29 U 2.9 
Lincomycin U 6.03 U 5.81 
Lomefloxacin U 6.71 U 5.81 
Miconazole U 3.01 U 2.9 
Norfloxacin U 47.2 U 29 
Norgestimate U 14.1 U 5.81 
Ofloxacin U 3.01 U 2.9 
Ormetoprim  3.02  2.37 
Oxacillin U H 6.03 U H 5.81 
Oxolinic Acid U 1.58 U 1.16 
Penicillin G U H 6.03 U H 5.81 
Penicillin V U 6.03 U 5.81 
Roxithromycin NQ  NQ  
Sarafloxacin U 30.1 U 29 
Sulfachloropyridazine U 3.01 U 2.9 
Sulfadiazine U 3.01 U 2.9 
Sulfadimethoxine  3.74  2.92 
 78
Sulfamerazine U 2 U 1.16 
Sulfamethazine U 4.82 U 1.16 
Sulfamethizole U 2.04 U 1.16 
Sulfamethoxazole U 1.73 U 1.73 
Sulfanilamide U 61.5 U 29 
Sulfathiazole U 3.01 U 2.9 
Thiabendazole U 3.01 U 2.9 
Trimethoprim U 3.01 U 2.9 
Tylosin U 12.1 U 11.6 
Virginiamycin M1 U 16 U 6.85 
1,7-Dimethylxanthine U 121 U 116 
% Moisture  0.46  67.3 
13C2-15N-
Acetaminophen (% 
Recovery) 
V 262  147 
13C3-Caffeine (% 
Recovery) V 157  113 
d10-Carbamazepine (% Recovery) 77.3  100 
13C3-15N-Ciprofloxacin (% 
Recovery) 105  139 
13C2-Erythromycin-H2O (% 
Recovery) 105  100 
D5-Fluoxetine (% Recovery) 55  89.6 
13C6-Sulfamethazine (% Recovery) 74.4  94 
13C6-Sulfamethoxazole (% 
Recovery) 103  99.2 
D6-Thiabendazole (% Recovery) 46  89.2 
13C3-Trimethoprim (% Recovery) 117  118 
Anhydrochlortetracycl
ine [ACTC] 
U 30.1 
 
33.3 
Anhydrotetracycline 
[ATC] 
U 30.1 U 29 
Chlortetracycline 
[CTC] 
U 13 U 11.6 
Demeclocycline U 30.1 U 29 
Doxycycline U 12.1 U 11.6 
4-
Epianhydrochlortetrac
ycline [EACTC] 
U 121 U 116 
4-
Epianhydrotetracyclin
e [EATC] 
U 30.1 U 29 
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4-Epichlortetracycline 
[ECTC] 
U 30.1 U 29 
4-Epioxytetracycline 
[EOTC] 
U 12.1 U 11.6 
4-Epitetracycline 
[ETC] 
U 12.1 U 11.6 
Isochlortetracycline 
[ICTC] 
U 12.1 U 11.6 
Minocycline U 121 U 116 
Oxytetracycline 
[OTC] 
U 12.1 U 11.6 
Tetracycline [TC] U 12.1 U 11.6 
% Moisture   0.46   67.3 
D6-Thiabendazole (% 
Recovery) 
  90.2   96.7 
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Table C.3. The concentration of each PPCPs detected in the chicken feather and chicken 
feather meal samples collected from Plant 3 in the U.S. 
 Chicken feather from Plant 3 Chicken feather meal from Plant 3 
Sample Size 0.476g (dry) 0.472g (dry) 
UNITS Flag ng g
-1 (dry weight 
basis) Flag ng g
-1 (dry weight basis) 
Acetaminophen U 31.5 U 31.8 
Azithromycin U 3.15 U 3.46 
Caffeine U 31.5 U 31.8 
Carbadox U 3.15 U 3.18 
Carbamazepine U 3.15 U 3.18 
Cefotaxime U 12.6 U 14.7 
Ciprofloxacin U 12.6 U 12.7 
Clarithromycin U 3.15 U 3.18 
Clinafloxacin U 12.6 U 31.2 
Cloxacillin U H 6.3 U H 6.36 
Dehydronifedipine U 1.26 U 1.27 
Diphenhydramine U 1.26 U 1.27 
Diltiazem U 0.879 U 0.705 
Digoxin U 12.6 U 16.2 
Digoxigenin U 31.6 U 63.6 
Enrofloxacin U 6.3 U 6.36 
Erythromycin-H2O U 4.83 U 4.87 
Flumequine U 3.15 U 3.18 
Fluoxetine U 3.15 U 3.21 
Lincomycin U 6.3 U 6.36 
Lomefloxacin U 6.3 U 7.38 
Miconazole U 3.15 U 3.18 
Norfloxacin U 31.5 U 31.8 
Norgestimate U 11.6 U 12.4 
Ofloxacin U 3.15 U 3.18 
Ormetoprim U 1.26 U 1.27 
Oxacillin U H 6.3 U H 6.36 
Oxolinic Acid U 1.26 U 1.27 
Penicillin G H 12.4 U H 6.36 
Penicillin V U 6.3 U 6.36 
Roxithromycin NQ  NQ  
Sarafloxacin U 31.5 U 31.8 
Sulfachloropyridazin
e U 3.15 U 3.18 
Sulfadiazine U 3.15 U 3.18 
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Sulfadimethoxine  0.823  13.5 
Sulfamerazine U 1.26 U 1.85 
Sulfamethazine U 1.54 U 2.59 
Sulfamethizole U 1.26 U 1.76 
Sulfamethoxazole U 1.61 U 3.15 
Sulfanilamide U 31.5 U 31.8 
Sulfathiazole U 3.15 U 3.18 
Thiabendazole U 3.15 U 3.18 
Trimethoprim U 3.15 U 3.18 
Tylosin U 12.6 U 12.7 
Virginiamycin M1 U 7.31 U 11.5 
1,7-Dimethylxanthine U 126 U 127 
% Moisture  56.3  3.67 
13C2-15N-
Acetaminophen (% 
Recovery) 
V 162 V 293 
13C3-Caffeine (% Recovery) 137 V 147 
d10-Carbamazepine (% Recovery) 96.1  93 
13C3-15N-Ciprofloxacin (% 
Recovery) 114  115 
13C2-Erythromycin-H2O (% 
Recovery) 94  116 
D5-Fluoxetine (% Recovery) 86.3  66 
13C6-Sulfamethazine (% Recovery) 89.7  89.4 
13C6-Sulfamethoxazole (% 
Recovery) 112  108 
D6-Thiabendazole (% Recovery) 79  46.9 
13C3-Trimethoprim (% Recovery) 113  133 
Anhydrochlortetracyc
line [ACTC]   32.2 U 31.8 
Anhydrotetracycline 
[ATC] U 31.5 U 31.8 
Chlortetracycline 
[CTC] U 12.6 U 15 
Demeclocycline U 31.5 U 31.8 
Doxycycline U 12.6 U 12.7 
4-
Epianhydrochlortetra
cycline [EACTC] 
U 126 U 127 
4-
Epianhydrotetracycli
ne [EATC] 
U 31.5 U 31.8 
4-
Epichlortetracycline 
[ECTC] 
U 31.5 U 35.7 
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4-Epioxytetracycline 
[EOTC] U 12.6 U 12.7 
4-Epitetracycline 
[ETC] U 12.6 U 12.7 
Isochlortetracycline 
[ICTC] U 12.6   41.7 
Minocycline U 126 U 127 
Oxytetracycline 
[OTC] U 12.6 U 12.7 
Tetracycline [TC] U 12.6 U 12.7 
% Moisture   56.3   3.67 
D6-Thiabendazole 
(% Recovery)   107   103 
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Table C.4. The concentration of each PPCPs detected in the DAF water-in samples 
collected from Plant 1 and Plant 2 in the U.S. 
 DAF-in solid from Plant 1 DAF-in solid from Plant 2 
Sample Size 0.566g (dry) 0.718g (dry) 
UNITS Flag ng g
-1 (dry weight 
basis) Flag ng g
-1 (dry weight basis) 
Acetaminophen U 26.5 U 20.9 
Azithromycin  17 U 2.66 
Caffeine  29.4 U 20.9 
Carbadox U 2.65 U 2.09 
Carbamazepine  16.2 U 2.09 
Cefotaxime U 17.6 U 8.36 
Ciprofloxacin  80.4 U 8.36 
Clarithromycin U 2.65 U 2.09 
Clinafloxacin U 13.1 U 30.8 
Cloxacillin U H 5.3 U H 4.18 
Dehydronifedipine U 1.06 U 0.836 
Diphenhydramine  5.11 U 0.836 
Diltiazem U 1.56 U 0.476 
Digoxin U 10.6 U 8.36 
Digoxigenin U 89.9 U 103 
Enrofloxacin U 5.3  5.11 
Erythromycin-H2O U 4.06 U 3.21 
Flumequine U 2.65 U 2.09 
Fluoxetine U 3.76 U 7.42 
Lincomycin U 5.3 U 4.18 
Lomefloxacin  7.12 U 4.18 
Miconazole U 2.65 U 2.09 
Norfloxacin U 26.5 U 24.7 
Norgestimate U 18.9 U 12.4 
Ofloxacin  9.74 U 2.09 
Ormetoprim U 1.06  1.36 
Oxacillin U H 5.3 U H 4.18 
Oxolinic Acid U 4.39 U 1.17 
Penicillin G U H 5.3 U H 4.18 
Penicillin V U 5.3 U 4.18 
Roxithromycin NQ  NQ  
Sarafloxacin U 26.5 U 20.9 
Sulfachloropyridazin
e U 2.65 U 2.09 
Sulfadiazine U 2.65 U 2.09 
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Sulfadimethoxine U 0.838  2.41 
Sulfamerazine U 4.01 U 2.38 
Sulfamethazine U 5.87 U 3.31 
Sulfamethizole U 1.76 U 1.32 
Sulfamethoxazole U 1.92 U 1.23 
Sulfanilamide U 26.5 U 20.9 
Sulfathiazole U 2.65 U 2.09 
Thiabendazole U 2.65 U 2.09 
Trimethoprim U 2.65 U 2.09 
Tylosin U 10.6 U 8.36 
Virginiamycin M1 U 15.2 U 10.1 
1,7-Dimethylxanthine U 106 U 83.6 
% Moisture  65.7  71.2 
13C2-15N-
Acetaminophen (% 
Recovery) 
V 187 V 24.8 
13C3-Caffeine (% 
Recovery) V 186 V 203 
d10-Carbamazepine (% Recovery) 69.5  102 
13C3-15N-Ciprofloxacin (% 
Recovery) 136 V 162 
13C2-Erythromycin-H2O (% 
Recovery) 82.6  112 
D5-Fluoxetine (% Recovery) 36.9  58.8 
13C6-Sulfamethazine (% Recovery) 49.5  61.7 
13C6-Sulfamethoxazole (% 
Recovery) 76.7  68.5 
D6-Thiabendazole (% Recovery) 47.7  75.2 
13C3-Trimethoprim (% Recovery) 92.4 V 160 
Anhydrochlortetracyc
line [ACTC]   29   24.2 
Anhydrotetracycline 
[ATC] U 26.5 U 20.9 
Chlortetracycline 
[CTC] U 11.2 U 8.6 
Demeclocycline U 26.5 U 20.9 
Doxycycline U 10.6 U 8.36 
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4-
Epianhydrochlortetra
cycline [EACTC] 
U 106 U 83.6 
4-
Epianhydrotetracycli
ne [EATC] 
U 26.5 U 20.9 
4-
Epichlortetracycline 
[ECTC] 
U 26.5 U 20.9 
4-Epioxytetracycline 
[EOTC]   22.8 U 8.36 
4-Epitetracycline 
[ETC] U 10.6 U 8.36 
Isochlortetracycline 
[ICTC] U 10.6 U 8.36 
Minocycline U 106 U 83.6 
Oxytetracycline 
[OTC]   66.5 U 8.36 
Tetracycline [TC] U 10.6 U 8.36 
% Moisture   65.7   71.2 
D6-Thiabendazole 
(% Recovery)   97.8   98.8 
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Table C.5. The concentration of each PPCPs detected in the peat moss samples, lab 
blank and OPR quality control group. 
 Peat moss Lab Blank  Spiked Matrix  
Sample Size 0.398g (dry) 0.500g   
UNITS Flag ng g
-1 (dry 
weight basis) Flag ng g
-1 Flag % Recovery 
Acetaminophen U 37.7 U 30  96.5 
Azithromycin U 3.77 U 3  24 
Caffeine U 37.7 U 30  85 
Carbadox U 3.77 U 3  73.9 
Carbamazepine U 3.77 U 3  118 
Cefotaxime U 15.1 U 12  113 
Ciprofloxacin U 363 U 63.6  88.9 
Clarithromycin U 3.77 U 3  98.8 
Clinafloxacin U 408 U 189  185 
Cloxacillin U H 7.55 U H 6 H N 201 
Dehydronifedip
ine U 1.51 U 1.2  98.5 
Diphenhydrami
ne U 1.51 U 1.2  92.4 
Diltiazem U 0.755 U 0.6  107 
Digoxin U 15.1 U 12  101 
Digoxigenin U 156 U 12  135 
Enrofloxacin U 32.4 U 12.3  133 
Erythromycin-
H2O  5.82 U 4.6  126 
Flumequine U 3.77 U 3  90.9 
Fluoxetine U 3.77 U 3  92.8 
Lincomycin U 7.55 U 6  163 
Lomefloxacin U 56.9 U 32.8  229 
Miconazole U 3.77 U 3  70.9 
Norfloxacin U 852 U 205  111 
Norgestimate U 11 U 6  93 
Ofloxacin U 3.77 U 3  183 
Ormetoprim U 1.51 U 1.2  83.5 
Oxacillin U H 7.55 U H 6 H N 152 
Oxolinic Acid U 1.51 U 1.2  105 
Penicillin G U H 7.55 U H 6 H N 146 
Penicillin V U 7.55 U 6 N 183 
Roxithromycin NQ  NQ  NQ  
Sarafloxacin U 37.7 U 30  151 
Sulfachloropyri
dazine U 3.77 U 3  127 
Sulfadiazine U 3.77 U 3  110 
Sulfadimethoxi
ne U 0.755 U 0.6  95.7 
Sulfamerazine U 2.42 U 1.2  94 
Sulfamethazine U 2.06 U 1.2  101 
Sulfamethizole U 1.51 U 1.2  70.9 
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Sulfamethoxaz
ole U 1.85 U 1.2  98.6 
Sulfanilamide U 55.4 U 30  57.9 
Sulfathiazole U 3.77 U 3  75.9 
Thiabendazole U 3.77 U 3  107 
Trimethoprim U 3.77 U 3  92.6 
Tylosin U 15.1 U 12  93.6 
Virginiamycin 
M1 U 13.1 U 6.61  134 
1,7-
Dimethylxanthi
ne 
U 151 U 120  175 
% Moisture  26.4     
13C2-15N-
Acetaminophen 
(% Recovery) 
V 183  119  119 
13C3-Caffeine 
(% Recovery)  129  87.6  109 
d10-Carbamazepine (% 
Recovery) 113  110  95.1 
13C3-15N-
Ciprofloxacin 
(% Recovery) 
V 4.48 V 6.24  16.6 
13C2-Erythromycin-H2O 
(% Recovery) 67.1  84.8  85.4 
D5-Fluoxetine (% 
Recovery) 54.5  77.5  79.1 
13C6-Sulfamethazine (% 
Recovery) 70.5  100  86.7 
13C6-Sulfamethoxazole (% 
Recovery) 108  111  101 
D6-Thiabendazole (% 
Recovery) 58.2  69.3  75.1 
13C3-Trimethoprim (% 
Recovery) 77.4  78.4  84.9 
Anhydrochlorte
tracycline 
[ACTC] 
U 44.9   40.2   38 
Anhydrotetracy
cline [ATC] U 37.7 U 30   34.9 
Chlortetracycli
ne [CTC] U 16.7 U 12   105 
Demeclocyclin
e U 37.7 U 30   56.9 
Doxycycline   21.6 U 12   80.6 
4-
Epianhydrochlo
rtetracycline 
[EACTC] 
U 151 U 120   13.8 
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4-
Epianhydrotetra
cycline [EATC] 
U 37.7 U 30   38.8 
4-
Epichlortetracy
cline [ECTC] 
U 38.5 U 30   107 
4-
Epioxytetracycl
ine [EOTC] 
U 15.1 U 12   74.5 
4-
Epitetracycline 
[ETC] 
U 15.1 U 12   111 
Isochlortetracyc
line [ICTC] U 15.1 U 12 MAX 70.2 
Minocycline U 151 U 120   14.8 
Oxytetracycline 
[OTC] U 15.1 U 12   93.8 
Tetracycline 
[TC] U 15.1 U 12   92.3 
% Moisture   26.4         
D6-
Thiabendazole 
(% Recovery) 
  56.3   74.7   75.5 
 
